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On 2 August 2019, the Government announced 
the launch of a Health Diversion Approach to 
the possession of drugs for personal use. The 
fi nal report of the Working Group to Consider 
Alternative Approaches to the Possession of Drugs 
for Personal Use and supporting documents were 
also published that day.1,2,3 Taking into consideration 
the fi ndings of this report and the range of 
stakeholder views, the Department of Health and 
the Department of Justice and Equality agreed to 
adopt a more health-led approach to possession 
for personal use.
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In brief
The theme of the National Drugs Forum for 2019 
is ‘Inclusion Health: responding to complex health 
needs of people who use drugs’. Inclusion health 
is an emergent approach to policy development, 
service delivery, and research. It seeks to explain 
the health impact for those living as part of a 
vulnerable and excluded population, and to 
work towards preventing and redressing the 
consequences of these determinants.
Health and social interventions based on an inclusion-health 
approach target people who are experiencing or have 
experienced homelessness, drug use, imprisonment, sex work, 
mental health difficulties, or other adverse life experiences 
that have led to social exclusion and marginalisation.
Interventions designed to improve physical and mental health 
must look beyond singular risk factors such as problematic 
drug use. They must respond to the multiple and complex 
needs of socially excluded populations who have common 
intersecting characteristics and adverse life experiences, such 
as childhood trauma and poverty. 
A research programme based on inclusion health principles 
will increase awareness of the need for preventive and early 
intervention approaches, the consequences of extreme 
inequity, and the importance of structural interventions. 
These include housing, employment, and legal support in 
reducing exclusion and supporting recovery.
The National Drugs Forum was fortunate to hear from two 
speakers who have made important contributions to the 
concept of inclusion health and the practical implications 
of configuring our healthcare and other services to meet 
the needs of our most vulnerable populations. We can now 
build on this learning and ensure that inclusion health is a key 
strand in the synthesis of evidence and experience informing 
the development of effective interventions in Ireland.
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The Health Diversion Approach offers alternatives to criminal 
prosecutions for the first two instances in which people are 
found in possession of drugs for their personal use. Essentially, 
the action taken by An Garda Síochána (AGS) will depend on the 
number of times an individual has been caught in possession.
• On the first occasion, AGS will refer them, on a mandatory 
basis, to the Health Service Executive (HSE) for a health 
screening and brief intervention.
• On the second occasion, AGS will have the discretion to 
issue an adult caution.
• On the third or any subsequent occasion, AGS will revert to 
dealing with the person in line with Section 3 of the Misuse 
of Drugs Act 1977, under which they could receive a criminal 
conviction and custodial sentence.
The health screening and brief intervention will be carried out 
by trained HSE staff using the Screening and Brief Intervention 
for Problem Alcohol and Substance Use (SAOR) programme. New 
posts will be created across the HSE’s Community Healthcare 
Organisation Areas for staff trained in SAOR to carry out the brief 
intervention. By November 2019, no further details were available 
on how the new approach will be implemented.
An implementation, monitoring, and evaluation group has been 
established to examine the need for legislative change, the 
operational details, and the phasing of the implementation. 
The group will be chaired by the Department of Health and its 
membership will include, but not be limited to, the HSE, AGS, 
and the Department of Justice and Equality. It is expected that 
this group will begin its work in Q4 2019, with the aim of phasing 
in the Health Diversion Approach in Q3 2020.
Other recommendations made by the Working Group, 
but which were not considered by Government, included 
that imprisonment would no longer be an outcome for the 
possession of drugs for personal use and that all related 
convictions could be spent.4
This issue of Drugnet Ireland looks at three other topics related 
to the new approach:
1 An overview of the final report of the Working Group, 
focusing on its recommendations.
2 A more detailed overview of the Working Group’s 
conclusions on the question of decriminalisation in the Irish 
context.
3 Stakeholder responses to the Working Group’s report and 
the Health Diversion Approach
1. Overview of Working Group’s final report
In December 2017, the Working Group to Consider Alternative 
Approaches to the Possession of Drugs for Personal Use 
was established. It was set up to deliver on a commitment in 
Ireland’s national drugs strategy to ‘consider the approaches 
taken in other jurisdictions to the possession of small 
quantities of drugs for personal use with a view to making 
recommendations on policy options to the relevant Minister 
within 12 months’ (p. 58).5 The group undertook a programme 
of research and consultation to identify alternatives to the 
current system and to consider which alternatives would be 
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appropriate in the Irish context.2,3 The group’s final report was 
published on 2 August 2019.1
Report overview
The report presents an overview of the current situation in 
Ireland in relation to the possession of drugs for personal 
use. It maps out Ireland’s current legislative regime and the 
rationale underpinning it as well as the current options available 
to the courts when prosecuting for simple possession. The 
report includes key findings from research commissioned 
by the Working Group on the legislative approach taken in 
Ireland compared with other jurisdictions, and outlines a set 
of possible options that could work in the Irish context. There 
is also an overview of the public consultation and various 
stakeholder presentations made in the course of the group’s 
work. Key findings from an examination of the costings of 
alternative approaches carried out by the Irish Government 
Economic and Evaluation Service (IGEES) in the Department 
of Justice are also included.3 The report outlines the Working 
Group’s considerations on a selection of policy approaches and 
their suitability to the Irish context.
Principles
In considering different policy approaches and making 
their recommendations, the Working Group identifies three 
principles that alternatives should address, while also being 
cognisant of potential difficulties imposed by Ireland’s legal 
system:
• A person should be afforded the opportunity to avoid a 
criminal conviction for the possession of drugs for their 
personal use
• A person should be supported to avoid, reduce and recover 
from drug-related harm
• A person with problematic drug use should be referred to 
appropriate treatment or other support (p. 58).1
Recommendations
In the final chapter of the report, the Working Group presents 
a set of recommendations. These are based on detailed 
discussion of the evidence gathered in the course of its work, 
its consultations and its discussions of the various alternatives. 
It recommends three policy options for the legislature to 
consider. It regards these as both workable in the Irish context 
and can address the concerns of Government and the public, 
albeit to varying degrees.
Option 1: Adult caution
• The Adult Cautioning Scheme is a discretionary alternative 
to prosecution, whereby a person found in possession of 
drugs for personal use could be given a formal caution by 
Gardaí, who could also provide the individual with a health 
and social services information leaflet.
Option 2: Multiple adult cautions
• Subject to the agreement of the Director of Public 
Prosecutions, a person could be given the benefit of an 
adult caution by Gardaí more than once. This could provide 
a discretionary alternative to prosecution and criminal 
conviction on more than one occasion.
• The individual would also be provided with a health and social 
services information leaflet, whenever they are given an adult 
caution in respect of possession of drugs for personal use.
Option 3: Diversion to health services
• This option is based on a public health approach to drug use.
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• A person in possession of drugs for personal use would 
be offered a diversion for a SAOR brief intervention and 
screening.
• A person with or at risk of problematic drug use would then 
be offered the appropriate onward referral for treatment or 
other supports.
In addition to these three policy options, the Working Group 
makes a set of other recommendations:
(a) That imprisonment, in principle, is no longer an outcome 
for the possession of drugs for personal use (subject 
to a full examination of the legal implications and any 
unforeseen consequences).
(b) That all convictions for drug possession for personal use 
can be spent.6 In addition, that the time between the 
conviction and it becoming spent be reduced from seven 
years to three years.
(c) That a dismissal or non-conviction under the Probation 
Act is recorded correctly so that it will be clear when the 
person’s records are being checked.
(d) That current legislation is not changed to include a 
threshold limit to distinguish between what is meant by 
personal use versus that for sale or supply.
(e) Given the nature of problem substance use as a chronic, 
often recurring condition, that there are pathways available 
at all levels of the criminal justice system to refer people to 
treatment following prosecution.
(f) That additional investment in services is made to meet the 
greater treatment demand that may come from any change 
in related policy.
(g) That there is a campaign to increase awareness of the 
treatments available and the harms associated with drug use. 
It mentions in particular those associated with cannabis use.
(h) That any alternative approach introduced in Ireland is 
monitored, has a data collection mechanism, an evaluation of 
the implementation, and scope for appropriate modification.
2. Working Group’s conclusions on 
decriminalisation in Irish context
The Working Group considered decriminalisation as one of 
the alternative policy approaches to dealing with possession 
for personal use in the Irish context. It was ultimately rejected 
by the Working Group and not considered by the Government 
when developing their Health Diversion Approach.
Portuguese approach
Decriminalisation has received a lot of attention among 
stakeholders over recent years and throughout the lifetime of 
the Working Group, in particular ‘the Portuguese approach’ (p. 
61).1 As defined by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA), under decriminalisation ‘the 
status of the offence is reclassified from a criminal offence 
to a non-criminal offence within a country’s legal framework. 
It is still an offence, it is still prohibited behaviour that will be 
stopped by police and punished, but it is no longer considered 
criminal’ (p. 27).1 Research commissioned by the Working Group 
described Portugal as using a model of ‘decriminalisation with 
targeted diversion to health/social services’ (p. 68).2
The Director of the National Unit to Combat Trafficking 
in Narcotic Drugs of Portugal’s Judicial Police made a 
presentation to the Working Group. He described how in 
Portugal the possession of drugs for personal use continues 
to be illegal. However, the offence is not a criminal one but 
is considered to be a misdemeanour for which a penalty 
or sanction can be applied. When a police officer finds 
a person in possession, they refer the person to a ‘drug 
dissuasion committee’ – this is a local administrative body 
for drug addiction, set up by Portugal’s Ministry for Health. 
The individual has a mandatory obligation to report to the 
committee on referral from a member of the police. There is 
no limit to the number of referrals an individual can get.
Suitability to Irish context
Having given ‘considerable time over the course of its 
meetings to examining how a similar approach could be 
adopted in Ireland’ (p. 61),1 the Working Group concluded 
that decriminalisation along the lines of that in Portugal was 
not suited to the Irish context. The decision is based on their 
understanding that the Irish legal system is not compatible 
with decriminalisation. Unlike most European Union countries, 
Ireland is a common law jurisdiction, not a codified civil law 
jurisdiction. The Working Group argues that there would be 
difficulties in applying decriminalisation (as defined by the 
EMCDDA) – in particular, that the concept of a criminal offence 
with an administrative or civil sanction would not be compatible 
with the Irish legal system. Decriminalisation would require an 
amendment to Section 3 of the Misuse of Drugs Act 1977 so 
that possessing drugs for personal use would no longer be an 
offence. The Working Group identified three main problems 
with making such a legislative change:
• The Gardaí would no longer have the power to stop and 
search a person for possession of drugs for their personal 
use. The Working Group considered whether Garda powers 
to stop and search based on public health considerations 
could be preserved if possession for personal use was 
decriminalised, and formed the view that this could give rise 
to constitutional and legal difficulties as no criminal offence 
would have been committed.
• Organised crime gangs could use the limits set for personal 
possession to facilitate a supply chain just below these 
thresholds. Although the report also notes that the 
‘Working Group understands that people involved in the 
sale and supply of drugs already carry minimum amounts 
of drugs in order to avoid criminal prosecution for sale or 
supply at present in Ireland’ (p. 61).1
• Removal of the offence could lead to de facto legalisation 
‘given that there would no longer be a criminal offence 
of possession for personal use’ (p. 67),1 and there may be 
unintended and undesirable consequences.
Recommendations
Given this context, the Working Group did not recommend the 
Portuguese model of ‘decriminalisation with targeted referral 
to services’ as appropriate for the Irish context. Instead, it 
concluded that the best way to mirror such an approach 
would be to continue to have possession for personal use as an 
offence, so that Gardaí have the power to stop and search but 
that they would also be able to divert people to appropriate 
services (p. 67).1 This rationale was cited by Minister for Health 
Simon Harris in his speech at the launch when explaining why 
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the Government decided not to decriminalise possession for 
personal use.7
3. Responses to Working Group’s report and 
Government’s Health Diversion Approach
The work and findings of the Working Group as well as the 
Government’s new approach have attracted much interest 
among stakeholders. The views of stakeholders vary and reflect 
the debate about whether possession for personal use calls 
for a health- or justice-led response. Some responses to the 
report and the Government’s approach are considered here.
Justice-led approach
The Working Group’s report includes addenda containing the 
views of three stakeholders, from the field of justice, on the 
report’s recommendations: namely, a representative of the 
Office of the Director of Public Prosecutions (ODPP), An Garda 
Síochána (AGS), and a Senior Lecturer in Law.1 The report does 
not describe the process through which these responses were 
selected for inclusion. The responses included:
• The ODPP considers that the removal of a custodial penalty 
(recommendation (a) above) would also remove from the 
options of community service orders and suspended 
sentences from the courts.
• As a response to possession for personal use, AGS does not 
support the introduction of multiple adult cautions (option 2 
above), the removal of a custodial penalty (recommendation 
(a) above), and has reservations about recommendation (b) 
that all such convictions could be spent.
• AGS criticises the report for not giving more consideration to 
the impact of the drugs market on organised crime in Ireland.
• AGS does not consider the Working Group to have fully 
explored the procedural and legal impediments to the 
alternative approaches and therefore does not recommend 
full adoption of the report’s findings.
• AGS supports recommendations (c)–(h) as outlined above.
Similar views are expressed by the chairperson of the Working 
Group in his minority report.8
Health-led approach
The Government’s decision to move towards a more health-led 
approach has been broadly welcomed by other stakeholders. 
However, there have been criticisms that the report’s 
recommendations and the Government’s approach have not 
gone far enough in the direction of health. Below are some of 
the views expressed in two stakeholder responses: an open 
letter to An Taoiseach signed by 52 civil society organisations 
(though sent prior to the launch of the report, it was based on 
‘indications’ of what the report would contain, which reflected 
accurate content) and an opinion piece from the Ana Liffey 
Drug Project.9,10
• The civil society representatives argue that implementing 
a health diversion approach while maintaining a criminal 
status for possession for personal use is ‘contradictory and 
lacking in logic’.9
• The value of limiting a person to only one opportunity to be 
diverted to a health intervention is challenged. Ana Liffey 
contends that ‘if drug use is a health issue the first time, it 
is a health issue the hundredth time’.10 It argues that this 
approach will further marginalise and stigmatise the most 
vulnerable users. Given the nature of their drug use and their 
circumstances, they are more likely to come into contact with 
AGS, and therefore will continue to be treated as criminals.
• Both responses challenge the assumptions that the ‘legal 
changes required to decriminalise possession for personal 
use would be too complicated’9 and that decriminalisation 
could not be made compatible with retaining the powers 
of AGS to stop, search, and confiscate drugs. Both call for a 
more detailed consideration of how appropriate legislation 
could be developed.
• Ana Liffey view the proposed Health Diversion Approach 
as unnecessarily ‘complicated and bureaucratic’ and argue 
that it does not represent ‘value to the taxpayer’.10
• The Government is criticised for not considering other 
recommendations of the Working Group. In particular, 
that imprisonment would no longer be an outcome for the 
possession of drugs for personal use and that all related 
convictions could be spent.6
Lucy Dillon
1 Working Group to Consider Alternative Approaches to the Possession 
of Drugs for Personal Use (2019) Report of the Working Group to 
Consider Alternative Approaches to the Possession of Drugs for 
Personal Use. Dublin: Department of Health and Department of 
Justice and Equality. https://www.drugsandalcohol.ie/30887/
2 Hughes C, Stevens A, Hulme S and Cassidy R (2019) Review of 
approaches taken in Ireland and in other jurisdictions to simple 
possession drug offences. A report for the Irish Department of 
Justice and Equality and the Department of Health. Sydney and 
Canterbury: University of New South Wales and University of Kent. 
https://www.drugsandalcohol.ie/30895/
3 Irish Government Economic and Evaluation Service (2019) Costings 
of an alternative approach to drug possession. Dublin: Department 
of Justice and Equality. https://www.drugsandalcohol.ie/30887/
4 Department of Health (2019) Ministers Harris, Flanagan, and Byrne 
announce health-led approach to the possession of drugs for 
personal use. Press release, 2 August 2019. Dublin: Department of 
Health. https://www.drugsandalcohol.ie/30888/
5 Department of Health (2017) Reducing harm, supporting recovery: a 
health-led response to drug and alcohol use in Ireland 2017-2025. 
Dublin: Department of Health. https://www.drugsandalcohol.ie/27603/
6 Under the provisions of the Criminal Justice (Spent Convictions 
and Certain Disclosures) Act 2016, an adult convicted of an offence 
covered by the Act does not have to disclose the conviction after 
seven years, except in certain circumstances.
7 Department of Health (2019) Speech by Minister Harris at launch 
of health diversion approach for drug use. 2 August 2019. Dublin: 
Department of Health. https://www.drugsandalcohol.ie/31070/
8 Sheehan G (2019) Minority report of Working Group to Consider 
Alternative Approaches to the Possession of Drugs for Personal 
Use. Dublin: Department of Health and Department of Justice and 
Equality. https://www.drugsandalcohol.ie/30887/
9  CityWide Drugs Crisis Campaign (2019) An open letter to Taoiseach Leo 
Varadkar. 15 July 2019. Dublin: CityWide Drugs Crisis Campaign. https://
www.citywide.ie/resources/open-letter-to-taoiseach-july-2019/
10 Keane M (2019) Opinion: The government’s new drug policy will do 
nothing to end the stigmatisation of drug users. Thejournal.ie, 7 
August 2019. https://www.drugsandalcohol.ie/30897/
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19 POLICY AND LEGISLATION 
Public Health 
(Alcohol) Act 2018
The Public Health (Alcohol) Act 20181 was signed into law by 
the President of Ireland on 17 October 2018. The Act faced 
much opposition from various interest groups and the three-
year interval between publication of the Bill and enactment of 
the Act was the longest ever in Ireland. This Act is particularly 
significant because, for the first time in Ireland, alcohol is being 
treated as a public health issue. The aim of the Act is to reduce 
alcohol consumption in Ireland and the harms it causes at a 
population level. There is a particular emphasis on reducing 
harm to young people and children, who are most vulnerable 
to the negative consequences of alcohol consumption. The 
first restrictions on advertising recently became law on 12th 
November.
Table 1: Summary of provisions of the Public Health (Alcohol) Act 2018 
Measure Rationale Commenced
Minimum unit pricing
Minimum unit pricing (MUP) for all products 
containing alcohol will be introduced and set at 10 
cent per gram of alcohol in the product. Unlike a 
tax increase where a retailer can choose to absorb 
the increase in price, MUP will be compulsory 
across all alcohol products. Under the new 
legislation:
• A 750 ml bottle of wine with a strength of 12% 
will cost a minimum of €7.10.
• A 700 ml bottle of vodka with a strength of 35% 
will cost at least €20.71.
• A 500 ml can of beer with a strength of 5% will 
cost a minimum of €1.97.
Research conducted by the Health Research 
Board and the Royal College of Surgeons in 
Ireland (RCSI) prior to the introduction of 
MUP indicated that the heaviest drinkers and 
those on lower incomes, such as students, 
buy the cheapest alcohol and are likely to be 
most affected by MUP.2 Currently, it is possible 
for a man to reach his weekly recommended 
alcohol limit for €7.48, while a woman can reach 
hers for just €4.84.3 Increasing the price of 
alcohol products reduces its affordability and 
reportedly is one of the most effective ways 
of reducing alcohol consumption and related 
harm.4
MUP has yet to be 
commenced.
Health warning labels
Section 12 of the Act stipulates that all alcohol 
products to be sold in Ireland will be required to 
display:
• A warning informing the public of the danger of 
alcohol consumption
• A warning outlining the danger of alcohol 
consumption when pregnant
• A warning informing the public of the direct link 
between alcohol and fatal cancers
• The quantity in grams of alcohol contained in 
the container concerned
• The calorie content in the container concerned
• Details of a website, to be established and 
maintained by the Health Service Executive, 
providing public health information in relation 
to alcohol consumption.
Health warning labels ensure the public 
have accurate information regarding the 
calorie content and alcohol strength of 
alcohol products and that they are informed 
of the health risks associated with alcohol 
consumption. Research published in a previous 
issue of Drugnet5 demonstrates that current 
public knowledge of the link between cancer 
and alcohol in Ireland is low. Just one-quarter 
of Irish women are aware of the direct link 
between alcohol and breast cancer, despite 
being the most common type of cancer 
experienced by women in Ireland.
This provision has yet 
to be commenced. 
Health warning labels 
on alcohol products 
are subject to 
approval at European 
level
Structural separation
Section 22 of the Act provides for the structural 
separation of alcohol products in mixed retail 
outlets (e.g. supermarkets and grocery stores). 
Retailers must choose from one of three options:
1 Store alcohol in an area of the store that is 
separated by a physical barrier.
2 Store alcohol products in one or more closed 
storage units or cabinets.
3 Store alcohol products in no more than three 
open storage units in the premises.
Limiting the physical availability of alcohol is 
an important population-based measure to 
reduce alcohol consumption. Interventions 
targeting the availability of alcohol at a 
population level have been found to be most 
effective in reducing alcohol-related harm and 
consumption.4
Structural separation 
was commenced on 
12 November 2018. By 
12 November 2020, all 
mixed-trade retailers 
will be obliged by law 
to physically separate 
alcohol products 
from other grocery 
items.
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Measure Rationale Commenced
Advertising
A range of restrictions will apply to the 
advertisement of alcohol products, with a 
particular emphasis on protecting children and 
young people. The main restrictions include:
• Content of advertisements will be restricted 
to specific information about the nature of the 
product.
• Advertisements must contain health warnings 
regarding alcohol consumption, including 
during pregnancy, and a link to a public health 
website.
• Advertisements in cinemas will be limited to 
films classified as over 18s.
• There will be a 9 p.m. broadcast watershed for 
advertisements on television and radio.
• The marketing and advertising of alcohol in 
the print media will be restricted in relation to 
volume and type of publication.
There will be a ban on advertising of alcohol 
products:
• In or near a school
• In or near an early years service (e.g. early years 
crèche)
• A park, open space or playground owned or 
maintained by a local authority
• On public transport
• In a train or bus station, and at a bus or Luas 
stop.
The Act will also restrict the sale of children’s 
clothing which promotes alcohol consumption or 
bears alcohol brands/products.
Advertising has been related to initiation 
of alcohol consumption, especially among 
children and adolescents, who are particularly 
vulnerable to advertising and marketing 
campaigns.6 Reducing children and young 
people’s exposure to alcohol advertising 
may delay initiation and reduce alcohol 
consumption among young people. Early 
initiation of alcohol use has been associated 
with a number of negative consequences for 
alcohol use, including increased likelihood of 
dependence later in life.7
Some of these 
measures have 
recently become law, 
including measures 
around advertising 
in the vicinity of 
children (Sections 14, 
20 and 17). Important 
measures yet to be 
commenced are: 
Section 13 on the 
restriction of the 
content of alcohol 
advertisements; 
Section 18 regarding 
limitations of 
advertising in the 
print media; and 
Section 19 regarding 
the broadcast 
watershed on alcohol 
advertising.
Sports sponsorship and sponsorship of other events aimed at children
With the exception of motorsport, the Act does not 
ban alcohol sponsorship of sport. However, Section 
15 of the Act prohibits advertising in sports grounds 
for events where the majority of competitors or 
participants are children or directly on a sports 
area for all events (e.g. on the actual pitch, the race 
track, tennis court, etc.). Alcohol sponsorship of 
other events aimed at children or where most of 
the participants are children will also be prohibited 
under Section 16.
As above, exposure to alcohol advertising 
and media has been associated with earlier 
initiation of drinking among adolescents and an 
increase in the volume of consumption among 
adolescents who already drink.6 Prohibiting 
advertising at events aimed at children will 
further limit exposure to alcohol advertising.
Both Section 15 
and Section 16 
were commenced 
in November 2018, 
with a three-year 
transition period.
Public Health (Alcohol) Act 2018  
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Measure Rationale Commenced
Restrictions on the sale and supply of alcohol products
Section 23 of the Act outlines a number of 
restrictions regarding the sale and availability of 
alcohol products. Several measures regarding 
limiting the sale and availability of alcohol 
products are outlined in the Act. One of the most 
important of these is the restriction of price-
based promotions, to which young people may be 
particularly sensitive.
Under Section 23, the Minister will have the power 
to make regulations around:
• The sale or supply of alcohol at a reduced price 
or free of charge to a certain target group
• The sale or supply of alcohol at a reduced 
price to someone because they have already 
purchased a certain quantity of alcohol or 
another service
• The sale or supply of alcohol during a limited 
time period (three days or less) that was less 
than the price charged for the same product 
the day before the offer was introduced
• Promotion of a business or event in a way that is 
likely to encourage people to drink alcohol in a 
harmful manner.
Restricting the sale and supply of alcohol 
products, particularly restricting price-based 
promotions, will reduce affordability and 
availability. Reducing the affordability and 
availability of alcohol products is the most 
effective way of reducing alcohol consumption 
at a population level.4
Section 23 was 
commenced in 
November 2018.
Public Health (Alcohol) Act 2018  
continued
Summary of the Act
Table 1 summarises some of the main provisions in the Act, their 
rationale, the measures introduced thus far, and those yet to be 
commenced. 
Conclusion
The Public Health (Alcohol) Act 2018 provides a number 
of evidence-based measures designed to reduce alcohol 
consumption at a population level. The first restrictions around 
alcohol advertising have now become law and several other 
provisions have been commenced. Timely implementation 
of the remaining provisions is needed given the current high 
rates of alcohol consumption, binge drinking, and alcohol 
dependence in Ireland.8,9
Claire O’Dwyer
1 Government of Ireland (2018) Public Health (Alcohol) Act 2018. 
Available online at: http://www.irishstatutebook.ie/eli/2018/
act/24/enacted/en/html
2 Cousins G, Mongan D, Barry J, Smyth B, Rackard M and Long J 
(2016) Potential impact of minimum unit pricing for alcohol in 
Ireland: evidence from the National Alcohol Diary Survey. Alcohol 
Alcohol., 51(6): 734–40. https://www.drugsandalcohol.ie/26346/
3 Alcohol Action Ireland (2019) Annual alcohol market review and 
price survey 2019. Dublin: Alcohol Action Ireland. Available online 
at: https://alcoholireland.ie/alcohol-action-ireland-release-
annual-alcohol-market-review-price-survey-2019/
4 Babor TF, Caetano R, Casswell S, Edwards G, Giesbrecht N, 
Graham K, et al. (2010) Alcohol: no ordinary commodity: research 
and public policy. 2nd edn. Oxford: Oxford University Press. 
https://www.drugsandalcohol.ie/16134/
5 O’Dwyer C and Mongan D (2019) Public awareness of alcohol-
related health conditions in Ireland: findings from the Healthy 
Ireland Survey. Drugnet Ireland, 70: 19-21.  
https://www.drugsandalcohol.ie/31013/
6 Anderson P, de Bruijn A, Angus K, Gordon R and Hastings G (2009) 
Impact of alcohol advertising and media exposure on adolescent 
alcohol use: a systematic review of longitudinal studies. Alcohol 
Alcohol, 44(3): 229–43.
7 Hingson RW, Heeren T and Winter MR (2006) Age at drinking onset 
and alcohol dependence: age at onset, duration, and severity. 
Arch Pediatr Adolesc Med, 160(7): 739–46.
8 Department of Health (2018) Healthy Ireland Survey 2018: 
summary of findings. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/29851/
9 Long J and Mongan D (2014) Alcohol consumption in Ireland 
2013: analysis of a National Alcohol Diary Survey. Dublin: Health 
Research Board. https://www.drugsandalcohol.ie/22138/
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What Works: 
Sharing Knowledge, 
Improving Children’s 
Futures 
The initiative of the Department of Children and Youth Affairs 
(DCYA), What Works: Sharing Knowledge, Improving Children’s 
Futures, was launched by Minister Katherine Zappone on 19 
June 2019. The event brought together key stakeholders in 
policy, provision, and practice communities.
What Works is a rebrand of the Quality and Capacity Building 
Initiative (QCBI) that DCYA has been developing since 2016. 
What Works seeks to embed and enhance knowledge and 
quality in prevention and early intervention in children and 
young people’s policy, service provision, and practice. There is 
a number of core strands to this work, including a data working 
strand; an evidence working strand; a professional development 
and capacity-building working strand; and finally a quality 
working strand.
Data working strand
The data working strand aims to improve access and use of 
data and information relating to children, young people, and 
their families by aligning and developing what currently exists in 
this area. The Outcomes for Children Data & Information Hub – 
https://outcomes4children.tusla.ie – which was also launched 
on 19 June, sets out to deliver on this aim. It aims to provide 
a sustainable, standardised technical solution for mapping 
outcomes and indicators for children and young people to aid 
in service planning, design, and delivery. It has been developed 
by Tusla, the Child and Family Agency, in conjunction with DCYA. 
It is publicly accessible and provides a web-based platform to 
visualise published data sets.
Evidence working strand
The evidence working strand aims to harness the learning from 
prevention and early intervention initiatives and research in 
order to actively support the use of this learning as a source 
and resource to inform planning, delivery, evaluation, and 
continuous improvements. This aim is in part met by the launch 
on 19 June of a dedicated website – https://whatworks.gov.
ie – which sets out to be a ‘go to’ source on what works best 
in prevention and early intervention in improving outcomes 
for children, young people, and their families. It is planned as 
a knowledge-exchange platform through which information 
on practice approaches, toolkits, practice guides, professional 
learning opportunities, and interventions and programmes can 
be accessed. However, an ‘evidence matrix’1 continues to be 
in the planning phase; this will involve the design of an ‘open 
access online guide/clearinghouse which will provide details 
and rated assessment of the costs and standards of evidence 
of impact of prevention and early intervention evidence based 
programmes globally and in Ireland’ (p. 3).1
Professional development and 
capacity-building working strand
The professional development and capacity-building working 
strand sets out to enhance the capacity and skills development 
of policymakers, providers, and practitioners in the appraisal 
and application of evidence-informed approaches in 
prevention and early intervention for children and young 
people through capacity building and development. The 
planned output under this working strand has evolved from 
being a standardised module of training in prevention and 
early intervention to a broader range of supports aimed at 
professional groupings in areas of need. A learning framework 
is under development but some of the related activities have 
been initiated. For example, DCYA’s partnership with the 
University of Limerick in the Research Evidence into Policy 
Programmes and Practice Project delivers short, focused 
executive leadership programmes in geographic/practice 
communities across Ireland. Action Learning Workshops with 
DCYA grantees have also been delivered.
Quality working strand
The quality working strand sets out to align, enhance, and 
sustain quality in prevention and early intervention as it relates 
to the development and delivery of policy, provision, and 
practice for children and young people. Development work is 
ongoing under this strand.
Lucy Dillon
1 Department of Children and Youth Affairs (2018) Request for tenders 
27 April 2018 for the development of evidence matrix for the Quality 
and Capacity Building Initiative. Dublin: Department of Children 
and Youth Affairs. https://www.drugsandalcohol.ie/29299/
Planet Youth in 
WRDATF 
In 2018, the Western Region Drug and Alcohol Task Force 
(WRDATF) committed itself to supporting the implementation 
of Planet Youth in parts of the region.1 As a first step, data 
were collected using the standardised Planet Youth tool with 
students in schools in participating areas. The results of these 
surveys are available on the programme’s Irish site,  
http://www.planetyouth.ie – launched in May 2019.
Planet Youth
Planet Youth is an evidence-based approach to preventing 
drug use. Developed in Iceland, the prevention model is 
predicated on three pillars of success: using evidence-based 
practice; using a community-based approach; and creating and 
maintaining a dialogue among research, policy, and practice. 
As outlined in more detail in an article in issue 66 of Drugnet 
Ireland in 2018, there are three broad elements to the model.1 
First, data are collected from young people (aged 15–16 years) 
through a school-based lifestyle questionnaire that is carried 
out biennially. This explores background factors, substance 
use, social circumstances, and potential risk factors associated 
with substance use. These data are then analysed to identify 
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19 Table 1: Findings related to substance misuse from the Planet Youth survey – percentage that reported activities 
Lifestyle activity Galway (%) Mayo (%) Roscommon (%)
Being drunk more than once in their lifetime 47 45 48
Being drunk in the last month 27 26 25
Lifetime cannabis use 19 15 17
Lifetime ecstasy use 4 2 3
Lifetime tranquiliser use 10 8 6
Drinking in pubs and clubs 19 23 27
Drinking in the homes of friends 26 26 32
Number of participants 2613 1397 480
the scope of the problem and map out the risk and protective 
factors experienced by the young people in that area.
The second element is where local stakeholders use the 
findings to plan and deliver a set of prevention responses – 
stakeholders include researchers, policymakers, practitioners, 
parents, school personnel, sports facilitators, recreational and 
extracurricular youth workers, and other interested community 
members. The third element is described as ‘integrative 
reflection’ (p. 19),2 whereby the impact of the interventions 
is measured through regular data collection, interventions 
amended in response to the findings, and any new issues 
identified.
Planet Youth in WRDATF
There are three Planet Youth pilot sites in Ireland – Planet 
Youth Galway, Planet Youth Mayo, and Planet Youth 
Roscommon. Each site has committed to a five-year pilot 
programme initiated by WRDATF with the support of partner 
agencies in the region. Local steering committees have been 
set up, which include funders and strategic partners. Data have 
been collected through the standardised lifestyle questionnaire 
in each of the three areas. A separate report has been 
produced for each area that includes the findings from each of 
the 77 questions and a variety of cross-tabulations.3,4,5
Findings
Table 1 shows the findings relating to substance misuse from the 
Planet Youth survey across the three pilot sites.
Other key findings included:
• Participants across the three counties who are involved in a 
sports club or a team are less likely to smoke cigarettes or 
use cannabis, but are more likely to report drunkenness.
• 30–32% agree somewhat or agree strongly that it is 
important to drink so that you are not left out of the peer 
group.
• Teenagers whose parents are less disapproving of 
drunkenness are more than twice as likely to have been 
drunk in the last month in Roscommon and Galway. This 
increased to two and a half times as likely in Mayo.
• Being out after midnight was associated with increased 
substance use. For example, in Mayo, teenagers who 
reported being out after midnight once or more in the past 
week were five times more likely to use cigarettes, two and 
a half times more likely to report drunkenness, and three 
times as likely to use cannabis. 
Conclusions and recommendations
Across the three reports, the authors draw the same 
conclusions from the data and make the same set of 
recommendations. Conclusions drawn include:
• There are positive findings around protective factors for 
young people in the area that could be used to shape 
primary prevention activities. The majority have good 
relationships with their parents and report being happy and 
safe in their schools and communities. Parent and family 
factors scored very highly with strong connections between 
parents and high levels of parental support and monitoring.
• The findings reflect what the authors term a ‘broad 
societal tolerance’ towards underage alcohol use. Alcohol 
use is seen as an integral part of Irish social life and also 
has a role in cultural and sporting activities. This cultural 
accommodation ‘permeates into adolescent decision-
making and norms and needs to be challenged’. In contrast, 
other drugs are not socially accepted in the same way and 
therefore are used less frequently and are not as tolerated 
in family or peer settings.
• A large proportion of young people in the three areas are 
active in sports and other extracurricular activities. The 
authors would have expected this to have been a protective 
factor for all substances, but it is not the case in any of 
the areas when it comes to alcohol use. They argue that 
consideration needs to be given as to why this is the case.
• Based on these findings, the authors make seven 
recommendations, under each of which is a set of 
suggested actions. The top level recommendations are:
1 Improve parental knowledge of the impact of alcohol  
 and other drugs.
2 Utilise the strong connections and communication  
 between young people and their parents.
3 Strengthen collaboration and connections between  
 families.
4 Improve parental knowledge of the impact of   
 unstructured leisure time on substance use.
5 Increase knowledge of peer factors related to   
 substance use.
6 Utilise and develop parental networks.
7 Decrease peer-facilitated access to alcohol and other  
 substances.
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Progress report 
on national drugs 
strategy for 2018
Ireland’s national drugs strategy Reducing harm, supporting 
recovery: a health-led approach to drug and alcohol use in 
Ireland 2017–2025 was launched in July 2017.1 The first progress 
report on the strategy was published in June 2019, namely 
Reducing harm, supporting recovery: progress 2018 and 
planned activity 2019.2
The progress report is structured around the three-year action 
plan that accompanied the strategy. The strategic action plan 
2017–2020 was embedded in the main strategy document and 
contains 50 actions with a brief description of how each is to 
be delivered. Lead agencies as well as any associated partners 
with responsibility for the delivery of each action are also 
identified. 
Lucy Dillon
1 Dillon L (2018) Planet Youth. Drugnet Ireland, 66 (Summer): 24. 
https://www.drugsandalcohol.ie/29607/
2 Sigfúsdóttir ID, Thorlindsson T, Kristjánsson AL, Roe KM and 
Allegrante JP (2009) Substance use prevention for adolescents: 
the Icelandic Model. Health Promot Int, 24(1): 16–25. 
http://www.drugsandalcohol.ie/28656/
3 Western Region Drug and Alcohol Task Force (WRDATF) (2019) 
Growing up in the west: county report Mayo. Galway: WRDATF. 
https://www.drugsandalcohol.ie/30531/
4 Western Region Drug and Alcohol Task Force (WRDATF) (2019) 
Growing up in the west: county report Roscommon. Galway: 
WRDATF. https://www.drugsandalcohol.ie/30532/
5 Western Region Drug and Alcohol Task Force (WRDATF) (2019) 
Growing up in the west: county report Galway. Galway: WRDATF. 
https://www.drugsandalcohol.ie/30528/
Planet Youth in WRDATF   continued
The strategy sets out a number of ways in which progress on 
its delivery would be monitored and assessed. Among these 
was that ‘the key bodies responsible for delivering the strategic 
actions will be required to report on progress on an annual 
basis to the Minister with responsibility for the National Drugs 
Strategy’ (p. 73).1 For this report, alongside each action, those 
responsible for its delivery were invited to report on progress in 
2017 and 2018, as well as ‘planned activity’ for 2019 and 2020.
 
The Drugs Policy Unit of the Department of Health is 
responsible for collating this feedback, and this report presents 
the first output from this work. The information reported is 
descriptive of tasks and activities carried out rather than of 
outcomes achieved. While information is not provided for all 
actions, it does provide a useful overview of progress in line 
with the strategic action plan 2017–2020.
Lucy Dillon
1 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 2017-
2025. Dublin: Department of Health. https://www.drugsandalcohol.
ie/27603/
2 Department of Health (2019) Reducing harm, supporting recovery: 
progress 2018 and planned activity 2019. Dublin: Department of 
Health. https://www.drugsandalcohol.ie/30660/
Hidden Harm 
strategic statement
As previously reported in issue 69 of Drugnet Ireland,1 the 
Health Service Executive (HSE) and Tusla, the Child and Family 
Agency, jointly launched the Hidden Harm strategic statement, 
Seeing through hidden harm to brighter futures,2 in January 
2019. The strategic statement outlines how these two State 
agencies will work together to bridge the gap between adult 
and children’s services in favour of a more family-focused 
approach in identification, assessment, and treatment that will 
improve the wellbeing and minimise the risk of hidden harm to 
children and families affected by alcohol and drug use.
Hidden harm definition
The experience of children living with parental problem alcohol 
and other drug use, and the resultant effect on them, is widely 
known as ‘hidden harm’. There are two key features to this 
term: first, the children are often not known to services; and, 
second, they suffer harm in a number of ways as a result of 
compromised parenting, which can impede the child’s social, 
physical, and emotional development (p. 8).2
Context
It is widely accepted that this is a significant problem in Irish 
society. Addressing hidden harm is a priority for Government, 
as reflected in the policy documents Better outcomes, brighter 
futures and Reducing harm, supporting recovery.3,4 Under the 
national drugs strategy’s first goal, to promote and protect 
health and wellbeing, Tusla and the HSE are the lead agencies 
on the strategic action to ‘mitigate the risk and reduce the 
impact of parental substance misuse on babies and young 
children’ (p. 31).4 Through the National Hidden Harm Project, 
they have committed to working together in a planned way 
to improve services and outcomes for children affected by 
parental problem alcohol and other drug use in Ireland.
Strategic statement
The strategic statement reflects this commitment and is 
grounded in an extensive body of work by stakeholders. This 
includes the work of the North South Alcohol Policy Advisory 
Group’s Subgroup on Hidden Harm; the Hidden Harm National 
Steering Group; learnings from national practice sites and input 
from a variety of stakeholders, including practitioners and 
managers from the Drug and Alcohol Task Forces, HSE Drug and 
Alcohol Services, and Tusla. It is seen by its authors as laying out 
‘the national standard upon which Hidden Harm work should 
be measured’ (p. 15).2 It applies not only to staff of both State 
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agencies but also to all voluntary and community groups in 
receipt of funding from HSE and Tusla, including the Drug and 
Alcohol Task Forces and their funded projects.
Vision of strategic statement 
The vision of the statement is for the two agencies ‘to work 
together effectively at the earliest possible stage to support 
children and families’ (p. 28). At its core, it focuses on the joint 
working and connecting practice of relevant stakeholders. To 
deliver on the vision, the statement outlines sets of strategic 
objectives, shared principles for partners, and common 
practice standards to guide practitioners:
Partnership may be described in this context as 
‘joint business’ between Tusla and the HSE. It is not 
expected that HSE Drug and Alcohol service staff 
become specialists in child welfare and protection, 
nor that Tusla staff become expert in drug and alcohol 
treatment and therapy. Rather, that through the 
implementation of this Statement, both Tusla and 
HSE staff develop deeper knowledge and practice 
application on Hidden Harm in a complementary way. 
(p. 17)2
Other activities
The statement is part of a suite of activities and outputs coming 
from this joint working. Other components are:
• Hidden Harm Practice Guide: This is an ‘educational 
resource to enhance knowledge and skills, in identifying 
and responding effectively to parental problem alcohol and 
other drug use in terms of its impact on children and to 
support the continuing professional development of health 
and social care practitioners’ (p. 2).5
• Information leaflet for practitioners: Opening our eyes 
to Hidden Harm aims to help frontline workers support 
children and young people affected by parental alcohol and 
other drug use. It includes key messages on the nature of 
hidden harm and how to find and offer support.6
• National interagency training programme for staff groups 
working within HSE and Tusla: This will be based on the 
practice guide and will encompass areas such as alcohol 
and drug theoretical frameworks and practice; child 
development and the impact of problem alcohol and other 
drug use; and attendant difficulties of mental health and 
domestic violence on parenting ability.
Lucy Dillon
1 O’Dwyer C (2019) Launch of new Hidden Harm initiative. Drugnet 
Ireland, 69 (Spring): 1–3. https://www.drugsandalcohol.ie/30627/
2 Health Service Executive (HSE) and Tusla (2019) Hidden Harm 
strategic statement: seeing through hidden harm to brighter 
futures. Dublin: HSE and Tusla. https://www.drugsandalcohol.
ie/30190/
3 Department of Children and Youth Affairs (2014) Better outcomes, 
brighter futures: the national policy framework for children and 
young people 2014–2020. Dublin: Stationery Office. https://www.
drugsandalcohol.ie/21773/
4 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 2017-
2025. Dublin: Department of Health. https://www.drugsandalcohol.
ie/27603/
5 Health Service Executive (HSE) and Tusla (2019) Hidden Harm 
practice guide: seeing through hidden harm to brighter futures. 
Dublin: HSE and Tusla. https://www.drugsandalcohol.ie/30190/
6 North South Hidden Harm Group (2019) Opening our eyes to 
Hidden Harm: empowering frontline workers to support children 
and young people affected by parental problem alcohol and other 
drug use. Dublin: HSE and Tusla. https://www.drugsandalcohol.
ie/30190/
Hidden Harm strategic statement 
continued
Minister of State at the 
Department of Health 
with responsibility for 
Health Promotion and 
the National Drugs 
Strategy Catherine 
Byrne TD opening the 
2019 National Drugs 
Forum in Croke Park  
on 5 November
13
Issue 71  |  Autum
n 2019      drugnet IRELAND      
Headshop legislation 
and changes in drug-
related psychiatric 
admissions
The impact of changes in legislation on drug-using behaviour 
is an area of interest for policymakers and other stakeholders. 
In 2017, a paper by Smyth et al. explored the relationship 
between changes in Ireland’s legislation related to new 
psychoactive substances (NPS) and their problematic use by 
looking at national drug treatment data.1 While acknowledging 
other possible explanations, the authors argued that their 
findings ‘are consistent with a hypothesis that the legislation 
and consequent closure of the headshops contributed to a 
reduction in NPS-related substance use disorders in Ireland’. 
They concluded that:
While policy responses based on prohibition type 
principals appear to have fallen out of favour globally 
in the past decade, the experience of Ireland’s 
response to NPS suggests that such policies remain 
a legitimate component of society’s response to this 
complex and ever-changing challenge.
A 2019 paper by Smyth et al. builds on this analysis by exploring 
the same research question using drug-related psychiatric 
admissions (DRPAs) data rather than treatment data.2
Context
As outlined in a Drugnet Ireland article on Smyth et al.’s 2017 
paper, in 2010, NPS were the subject of two pieces of legislation 
in Ireland.3 The first (enacted in May 2010) expanded the list 
of substances controlled under the Misuse of Drugs Acts 
1977−1984 to include over 100 NPS.4 The second, the Criminal 
Justice (Psychoactive Substances) Act 2010 (enacted in August 
2010), differed from the established approach to drug control 
under Ireland’s Misuse of Drugs Act, in that it covered the sale 
of substances by virtue of their psychoactive properties, rather 
than the identity of the drug or its chemical structure. It was 
aimed at vendors of NPS and effectively made it an offence to 
sell a psychoactive substance.5 This ‘two-pronged legislative 
approach’ was largely in response to an increase in the number 
of so-called ‘headshops’ selling NPS from late 2009 to a peak of 
102 premises in May 2010. By October 2010, only 10 headshops 
were still open and by late 2010 An Garda Síochána indicated 
that none of the remaining shops were selling NPS.
Legislative bans such as these have attracted international 
debate as to their effectiveness in impacting on the overall 
availability and use of NPS, in particular problematic use.6 In 
their 2019 paper, Smyth et al. hypothesised that ‘the expansion 
and subsequent abrupt closure of headshops in Ireland might 
cause changes to acute psychiatric presentations linked to NPS’ 
(p. 2).
Methods
The paper is based on analysis of data from the National 
Psychiatric In-Patient Reporting System (NPIRS) database, 
which collates data from every psychiatric inpatient unit in 
the Republic of Ireland. When a patient is discharged from 
one of these units, the clinical team identifies the primary and 
any additional diagnoses that led to an admission. Smyth et al. 
focused on DRPAs defined as either primary or any secondary 
discharge diagnosis that was in the F11–F19 ICD-10 diagnostic 
categories (International Statistical Classification of Diseases 
and Related Health Problems). Analysis included all DPRAs 
between 2008 and 2012 of people aged between 18 and 34 
years. As there is no unique patient identifier in Ireland, the 
unit of analysis was episode of admission, not individual patient. 
Data are not collected on the drug used by the DRPA, so 
analysis is not linked specifically to NPS.
Statistical analysis was carried out to answer three core 
questions:
• Do DRPAs differ from other admissions in the age range 
18–34? To contrast proportions, the authors used chi-
squared tests, reporting odds ratios and estimates of 
the 95% confidence interval (CI). Twelve per cent of all 
admissions for the period under study (2008–2012) were 
DRPAs. When compared with non-drug-related admissions, 
DRPAs were more likely to be male, younger, have unstable 
accommodation, be single/divorced, and have less skilled 
work.
• Did the rate of DRPA increase during the ‘headshop era’ 
(January–August) in 2010? The authors found that the rates 
of admission in 2010 were significantly higher than in 2008, 
2009, and 2012 (p<0.01) (see Table 1).
• Was there evidence of trend changes in DRPA and did 
these coincide with the arrival and departure of the 
headshops? The authors used the Joinpoint regression
Table 1: Rates of drug-related psychiatric admissions per month among 18–34-year-olds, comparing the headshop era of January to August 
2010 with the same period in other years 
Year Monthly rate/100 000 Comparison with 2010
Median (IQR) P value
2008 4.8 (3.9 to 5.7) 0.003
2009 5.0 (4.4 to 5.6) 0.005
2010 6.1 (5.6 to 6.6) n/a
2011 5.7 (4.9 to 6.0) 0.065
2012 5.0 (4.9 to 5.8) 0.003
Source: Smyth et al., 2019, Table 3, p. 52
IQR = Interquartile range.
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analysis that identified a significant downward trend change, 
which occurred in July 2010 (85% CI: Feb 2010 to April 2011). 
Males aged 18 to 24 years showed the greatest change, with 
DRPA falling by 1.4% per month (95% CI: 0.7 to 3.7% decline) 
from May 2010 to December 2012.
Conclusion
The authors argue that the timing of the changes found 
coincide with the advent of the headshop era and the 
subsequent introduction of legislation that essentially banned 
the sale of NPS in Ireland. In their discussion, the authors 
present these findings alongside the reduction in NPS-related 
treatment episodes found in their 2017 paper, and an 80% 
decline in NPS youth over the 4 years following 2010.7 The 
authors use this evidence to argue that while they recognise 
that correlation does not prove causation, their ‘findings lend 
weight to the view that the steps taken in Ireland to address 
NPS were associated with a positive public health impact’ (p. 7).
Meeting the needs 
of BME communities 
– organisational 
connector models
In 2017, CityWide Drugs Crisis Campaign produced the report, 
Stimulating and supporting a black and minority ethnic voice 
on drug issues.1 The research aimed ‘to explore possible 
structures and processes through which to engage with, hear 
the voice of, and empower Black and minority ethnic [BME] 
communities in relation to issues of drug use’ (p. 5). The report 
concluded that problematic drug use was an issue facing 
BME communities in Ireland, that there were challenges in 
addressing it, and that the needs of these communities were 
not being met by policymakers or service providers. A summary 
of the key findings of this report was provided in a 2018 issue 
of Drugnet Ireland.2 As a follow-up to this report, in 2019, 
CityWide published Taking steps to engage with black and 
minority ethnic communities and their organisations on issues 
related to problematic drug use.3 As with the previous report, 
the current one is written by Niall Crowley, an independent 
public policy researcher with expertise in human rights and 
equality.
Taking steps outlines the measures that can be taken by 
policymakers, service providers, Drug and Alcohol Task Forces 
(DATFs), and BME community organisations to better address 
the needs of BME communities in relation to problematic drug 
use. It describes two organisational connector models. In terms 
of definition, organisational connectors are described as ‘local 
organisations that have a strong relationship with and include 
members of Black and minority ethnic communities in their 
day-to-day work. They include schools, youth organisations, 
churches and minority ethnic businesses’ (p. 10). Organisational 
connectors enable service providers to more effectively 
engage and communicate with BME communities. Two models 
of working with organisational connectors based on the 
experiences of two DATFs and other service providers form the 
main body of the report.
Engaging and networking with schools and 
youth organisations
The DATF in Dublin’s north inner city engaged and networked 
schools and youth organisations as organisational connectors 
in making links with BME communities. The aim of their 
collaboration was to ensure that young BME people were 
supported, in integrated settings, to access information 
in relation to problematic drug use; explore and develop 
their thinking in relation to drug use; and build a network of 
supportive contacts.
• Key steps for the DATF included: Liaising with home school 
liaison officers and school principals; getting relevant youth 
organisations involved in its structures and work processes; 
and developing accessible materials on available supports 
that took account of the diversity of young people in their 
area.
• Key steps for the schools included: Facilitating and 
supporting the work of the DATF and local youth 
organisations, particularly supporting the participation of 
young people from BME communities to these activities.
• Key steps for the youth organisations included: Creating 
the conditions for integrated activities and building a 
culture of equality and celebrating diversity.
Lucy Dillon
1 Smyth BP, Lyons S and Cullen W (2017) Decline in new psychoactive 
substance use disorders following legislation targeting headshops: 
evidence from national addiction treatment data. Drug Alcohol Rev, 
36(5): 609–17. http://www.drugsandalcohol.ie/27172/
2 Smyth BP, Daly A, Elmusharaf K, McDonald C, Clarke M, Craig S, et 
al. (2019) Legislation targeting head shops selling new psychoactive 
substances and changes in drug-related psychiatric admissions: 
a national database study. Early Interv Psychiatry, Early online. 
https://www.drugsandalcohol.ie/30436/
3 Dillon L (2017) Headshop legislation and changes in national 
addiction treatment data. Drugnet Ireland, 62 (Summer): 13–14. 
https://www.drugsandalcohol.ie/27740/
4 Misuse of Drugs (Amendment) Regulations 2010. Available online 
at: http://www.irishstatutebook.ie/eli/2010/si/200/made/en/pdf
5 Criminal Justice (Psychoactive Substances) Act 2010 
(Commencement) Order 2010. Available online at:  
http://www.irishstatutebook.ie/eli/2010/si/401/made/en/pdf
6 Dillon L (2016) New psychoactive substances: legislative changes 
in the UK. Drugnet Ireland, 59 (Autumn): 9−10. http://www.
drugsandalcohol.ie/26231/
7 National Advisory Committee on Drugs and Alcohol (NACDA) (2016) 
Prevalence of drug use and gambling in Ireland and drug use in 
Northern Ireland 2014/15: Regional Drug and Alcohol Task Force 
(Ireland) and Health and Social Care Trust (Northern Ireland) 
results. Bulletin 2. Dublin: NACDA. https://www.drugsandalcohol.
ie/26901/
Headshop legislation   continued
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Engaging local development companies
The Cork Local Drug and Alcohol Task Force engaged with Cork 
City Partnership (CCP) to make links with BME communities 
in their area. CCP is a local development company and 
implements the Social Inclusion and Community Activation 
Programme (SICAP), which aims to strengthen community 
development, provide education and training, and support 
employment. The aim of their collaboration included more 
involvement of BME communities in the workings of the local 
DATF and expanding the resources available to respond to 
and prevent problematic drug and alcohol use within these 
communities. As well as providing opportunities to interact 
with BME communities, as a local development company 
with a remit to address social exclusion and inequality, CCP 
can provide opportunities to access education, training, and 
employment programmes.
Conclusion
The report concludes with an extract from CityWide’s 
submission to the Health Service Executive’s consultation for 
the Second National Intercultural Health Strategy 2018–2023, 
which was launched in January 2019.4 It has an action to 
implement the relevant elements of the national drugs strategy, 
Reducing harm, supporting recovery: a health-led response to 
drug and alcohol use in Ireland 2017–2025.5
Lucy Dillon
1  Crowley N (2017) Stimulating and supporting a black and minority 
ethnic voice on drugs issues. Dublin: CityWide Drugs Crisis 
Campaign. https://www.drugsandalcohol.ie/27501/
2 Dillon L (2018) Problematic drug use and the needs of new 
communities and BME groups. Drugnet Ireland, 64 (Winter): 26–27. 
https://www.drugsandalcohol.ie/28577/
3 Crowley N (2018) Taking steps to engage with black and minority 
ethnic communities and their organisations on issues related to 
problematic drug use. Dublin: CityWide Drugs Crisis Campaign. 
https://www.drugsandalcohol.ie/30443/
4 Health Service Executive (2018) Second National Intercultural 
Health Strategy 2018–2023. Dublin: Health Service Executive. 
https://www.drugsandalcohol.ie/30767/ 
5 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 2017-
2025. Dublin: Department of Health. https://www.drugsandalcohol.
ie/27603/
Meeting the needs of BME 
communities   continued
PREVALENCE AND CURRENT SITUATION
Has an increase in 
the dispensing of 
pregabalin influenced 
poisoning deaths in 
Ireland?
Introduction
Deaths caused by the toxic effect of drugs (poisoning deaths) 
are preventable and good clinical practice with supporting 
legislation can help prevent such deaths. Irish data on poisoning 
deaths show an increase in direct pregabalin-related poisoning 
deaths from the years 2013 to 2016.1 Of note, pregabalin 
– a prescribed medicine used in the treatment of several 
medical conditions, including epilepsy, neuropathic pain, and 
generalised anxiety disorder – has only been included in the 
routine postmortem toxicology screen by the State Laboratory 
since 2013.
Following the introduction of pregabalin in 2004, international 
evidence found an increase in its prescription rates.2,3,4 Fatal 
overdoses related to pregabalin have been reported and are 
almost always in combination with other drugs.5,6 The aim of 
this study was to examine whether or not the increase in the 
dispensing of pregabalin has impacted on poisoning deaths in 
Ireland between 2013 and 2016.
Methods
Prescription data were retrieved from the Health Service 
Executive (HSE) Primary Care Reimbursement Service (PCRS) 
annual reports,7 which record payment and prescription 
frequency for several services in Ireland. These services include 
the General Medical Services (GMS), which in 2014 related to 
43% of the general population,8 and services that cover the 
remainder of the population; data on drugs provided through 
the Long-Term Illness Scheme (LTI), which covers free drugs 
for the treatment of specific long-term illnesses; and data on 
repayments through the Drugs Payment Scheme (DPS), which 
reimburses any citizen who pays more than a set amount 
monthly for medicines.
Data on all poisoning deaths for the years of death 2013–2016 
with positive toxicology for pregabalin were extracted from the 
National Drug-Related Deaths Index (NDRDI). The NDRDI is an 
epidemiological census which records all poisoning deaths by 
drug(s) and/or alcohol. It also records non-poisonings deaths 
among persons who have a history of drug and/or alcohol 
dependence or misuse of drugs. The NDRDI’s main data source 
is coronial files. All postmortem toxicological analyses included 
in this report were performed by the State Laboratory in 
Ireland. Further details on the NDRDI methodology can be 
found in a previous Health Research Board publication.9
Descriptive statistics are presented for the number of 
dispensings and deaths over time. In addition, correlational 
analysis using linear regression was applied to estimate the 
relationship between number of dispensings for pregabalin and 
deaths over the reported time period. 
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19 Pregabalin influenced poisoning 
deaths   continued
Table 1: PCRS pregabalin dispensing frequency, number of poisoning deaths with a pregabalin-positive toxicology, and percentage of deaths 
related to PCRS dispensing, by year, 2013–2016 
Year of death 2013 2014 2015 2016
Total PCRS pregabalin items dispensed* 612 641 661 788 715 502 755 159
Breakdown of PCRS pregabalin items by scheme:
GMS 519 187 559 421 608 801 652 013
DPS 85 210 89 183 89 844 85 321
LTI 8244 13 184 16 857 17 825
All NDRDI poisoning deaths 400 370 365 354
Pregabalin-positive toxicology poisoning deaths 18 53 75 94
Percentage of deaths related to pregabalin items dispensed (%) 0.0029 0.008 0.01 0.012
*These figures do not include private pregabalin items dispensed that do not fall into these categories.
Results 
For the years of death 2013–2016 inclusive, the NDRDI recorded 
a total of 1489 poisoning deaths. Pregabalin was present on 
toxicology reports of 240 (16%) poisoning deaths during this 
period, increasing from 18 (4.5%) in 2013 to 94 (26%) in 2016, 
indicating an upward trend (χ2 = 74.626, p=<0.001) in the 
presence of pregabalin in poisoning deaths (see Table 1). The 
numbers of dispensed pregabalin items are shown in Table 1; 
these numbers increased year on year. Figure 1 shows a strong 
positive correlation between the number of pregabalin items 
dispensed through the HSE PCRS scheme and the number of 
poisoning deaths where pregabalin was present on toxicology 
reports over time, with a coefficient (R2) value of 0.9843.
Figure 1: Relationship between the number of pregabalin items dispensed and pregabalin-positive poisoning deaths, NDRDI 2013–2016
Discussion 
This ecological study shows that pregabalin-positive poisoning 
deaths are increasing in line with the increased dispensing 
of pregabalin in Ireland. In the United States, it has been 
suggested that the increase in prescribing pregabalin is related 
to clinicians using it outside its licensed indicated use, as an 
alternative to opioids for a variety of pain management.2 Since 
April 2019, in the United Kingdom, following recommendations 
from the Advisory Council on the Misuse of Drugs,10 pregabalin 
(and gabapentin) has been classified as a Class C drug. This 
means that pregabalin cannot be repeat-dispensed and 
prescriptions will only be valid for one month. Despite the 
acknowledgement that this will incur extra work for doctors, 
pharmacists, and especially patients, the medical profession in 
general supports this change.11 Results from our study support 
the consideration of similar reclassification of pregabalin in 
Ireland. In Ireland, the HSE issued correspondence in June 
2016 in relation to the dangers associated with prescribing 
pregabalin;12 however, this needs to be supported with tighter 
controls through legislative changes.
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National Self-Harm 
Registry annual 
report, 2017
The 16th annual report from National Self-Harm Registry 
Ireland was published in 2018.1 The report contains information 
relating to every recorded presentation of deliberate self-harm 
to acute hospital emergency departments in Ireland in 2017 
and complete national coverage of cases treated. All individuals 
who were alive on admission to hospital following deliberate 
self-harm were included, along with the methods of deliberate 
self-harm that were used. Accidental overdoses of medication, 
street drugs or alcohol were not included.
Rates of self-harm
There were 11,600 recorded presentations of deliberate self-
harm in 2017, involving 9,103 individuals. Taking the population 
into account, the age-standardised rate of individuals 
presenting to hospital in the Republic of Ireland following 
self-harm was 199 per 100,000 population. This was 3% lower 
than the rate recorded in 2016 (206 per 100,000 population). 
In recent years, between 2011 and 2013, there have been 
successive decreases in the self-harm rate. Nevertheless, the 
rate in 2017 was still 6% higher than in 2007, the year before the 
economic recession (see Figure 1).
In 2017, the national male rate of self-harm was 181 per 100,000 
population, 2% lower than in 2016. The female rate was 218 per 
100,000 population, which was 4% lower than in 2016. With 
regard to age, the peak rate for men was in the 20–24-age 
group, at 505 per 100,000 population. The peak rate for women 
was among 15–19-year-olds, at 758 per 100,000 population.
Self-harm and drug and alcohol use
Intentional drug overdose was the most common form of 
deliberate self-harm reported in 2017, occurring in 7,531 
(64.9%) of episodes. As observed in 2016, overdose rates were 
higher among women (70.3%) than among men (58.1%). Minor 
tranquillisers and major tranquilisers were involved in 34% and 
9% of drug overdose acts, respectively. In total, 33% of male 
and 47% of female overdose cases involved analgesic drugs, 
most commonly paracetamol, which was involved in 29% of 
all drug overdose acts. In 67% of cases, the total number of 
tablets taken was known, with an average of 29 tablets taken in 
episodes of self-harm that involved a drug overdose.
There was a 7% increase (n=583) in the number of 
presentations involving street drugs (cannabis, ecstasy, and 
cocaine) compared with 2016 (n=547). The 2017 levels are the 
highest recorded since 2008 and the second-highest ever 
recorded by the registry. Alcohol was involved in 31% of all self-
harm presentations, and was significantly more often involved 
in male episodes of self-harm than females (33% vs 29%, 
respectively). The authors reported that, as in previous years, 
alcohol continued to be one of the factors associated with the 
higher rate of self-harm presentations on Sundays, Mondays 
and public holidays, and in the hours around midnight.
Conclusions
The authors concluded that these findings underline the need 
for ongoing efforts:
• To reduce access to minor tranquillisers and other 
frequently used drugs, including paracetamol
• To intensify national strategies to increase awareness of 
mental health issues
• To intensify further strategies to reduce access to alcohol.
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19 National Self-Harm Registry 
annual report, 2017   continued
Seán Millar
1 Griffi  n E, Dillon CB, McTernan N, Arensman E, Williamson E, Perry 
IJ et al. (2018) National Self-Harm Registry Ireland annual report 
2017. Cork: National Suicide Research Foundation. https://www.
drugsandalcohol.ie/29774/
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Figure 1: Person-based rate of deliberate self-harm from 2002 to 2017 by gender
Source: National Suicide Research Foundation, 2018
‘All’ in the legend refers to the rate for both men and women per 100,000 population.
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Trends in addiction 
treatment in Irish 
prisons
In 2008, the National Drug Treatment Recording System 
(NDTRS) began to collect information on drug treatment in 
Irish prisons, mainly from in-reach voluntary services which 
provided counselling only. Up to 2013, the medical units of the 
Irish Prison Service did not participate in the NDTRS; however, 
in 2014, the medical unit in the largest male prison provided 
data on opiate substitution treatment and detoxification. Many 
studies have shown that incarcerated populations have a higher 
rate of problem drug and alcohol use compared with the 
general population. Prison treatment services are therefore an 
important source of data for gaining a better understanding of 
the trends in problem drug and alcohol use, and for informing 
service design and delivery. A recent Irish study1 analysed 
trends in addiction treatment demand in prisons in Ireland from 
2009 to 2014 using available national surveillance data in order 
to identify any implications for practice and policy.
In this research, published in the International Journal of 
Prisoner Health, national surveillance data on treatment 
episodes for problem drug and alcohol use from 2009 to 2014, 
collected annually by the NDTRS, were analysed. In total, 6% 
of all treatment episodes recorded by the NDTRS between 
2009 and 2014 were from prison services. It was found that the 
number of prison service treatment episodes increased from 
964 in 2009 to 1,063 in 2014. Opiates were the main reason 
for treatment, followed by alcohol, cocaine, and cannabis (see 
Table 1). The majority (94–98%) of treatment episodes involved 
males (median age 29 years) and low educational attainment, 
with 79.5–85.1% leaving school before completion of second 
level. The percentage of treatment episodes with a history of 
ever injecting drugs increased from 20.9% in 2009 to 31.0% in 
2014.
The authors observed that this is the first study to analyse 
treatment episodes in prison using routine surveillance data 
in Ireland and provides a baseline from which to measure any 
changes in provision of treatment in prison over time. Research 
on trends in addiction can help policy development and service 
planning in addiction treatment in prison, as it provides an 
insight into the potential needs of incarcerated populations.
Seán Millar
1 Cannon A, Nally F, Collins A, Fay R and Lyons S (2019) Trends in 
addiction treatment in Irish prisons using national surveillance 
data, 2009–2014. Int J Prison Health, 15(2): 105–13. https://www.
drugsandalcohol.ie/30318/
Table 1: Number of treatment episodes in Irish prisons and main problem drug, NDTRS (2009–2014) 
2009 2010 2011 2012 2013 2014
No. of treatment episodes 964 1096 1033 913 1015 1063
% of total committed 7.8 8.0 7.4 6.6 7.8 7.9
Main problem drug
Opiates 502 570 435 307 436 471
52.1% 52.0% 42.1% 33.6% 42.9% 44.3%
Alcohol 177 167 272 271 268 219
18.4% 15.2% 26.3% 29.7% 26.4% 20.6%
Cocaine 146 157 116 114 84 110
15.1% 14.3% 11.2% 12.5% 8.3% 10.3%
Cannabis 81 115 104 107 123 121
8.4% 10.5% 10.1% 11.7% 12.1% 11.4%
Hypnotics and sedatives 47 73 83 91 92 132
4.9% 6.7% 8.0% 10.0% 9.1% 12.4%
Stimulants 8 7 11 9 8 9
0.8% 0.6% 1.1% 1.0% 0.8% 0.8%
Others* ** 7 12 14 ** **
0.3% 0.6% 1.2% 1.5% 0.4% 0.1%
Source: Cannon et al., 2019
* Includes volatile inhalants.
** To protect against indirect identification of individuals, items with less than five entries have been removed
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19 Hepatitis C virus 
screening and 
treatment in Irish 
prisons from a 
governor and prison 
officer perspective
Unsafe injecting drug use is the main route of hepatitis C virus 
(HCV) transmission in developed countries, with an estimated 
20 million people who inject drugs (PWID) infected worldwide.1 
Over one-half of Irish prisoners report a history of opiate 
use, with 43% reporting a history of injecting.2 A 2000 study 
estimated the prevalence of HCV infection in the Irish prison 
population at 37%, increasing to 81% in those with a history of 
injecting drug use.3 With recent advances in treatment regimes, 
HCV is now a curable and preventable disease and prisons 
are a key location to access HCV-infected PWID. However, 
despite international guidelines recommending that prisons are 
a priority location for HCV screening and treatment, levels of 
prisoner engagement in HCV care remain low.
A recent Irish study aimed to explore prison governors’ and 
officers’ views on barriers and enablers to HCV screening 
and treatment.4 In this research, published in the BMC journal 
Health & Justice, five focus group sessions were conducted 
among two grades of security staff: the prison governor and 
the prison officer. The governor component of the study 
was national in coverage and included input from 13 of the 15 
prisons in the Republic of Ireland. For convenience and due to 
restricted access to other prison locations, the prison officer 
focus groups were confined to two Dublin prisons: Mountjoy 
male prison and the Dóchas Centre female prison.
Results
The following themes relating to barriers and enablers to both 
HCV screening and treatment emerged from the focus groups. 
Priority of safety and security 
All focus groups included discussions about issues of security 
and safety in their prisons. While supportive and understanding 
of the benefits of prison healthcare, their primary focus was to 
ensure the safety of both staff and inmates. In particular, prison 
staff reported security concerns related to the protection of 
prisoners and how burgeoning gangland feuds and rival factions 
made their jobs very difficult. This created barriers to both 
HCV screening and treatment since it reduced face-to-face 
time with prisoners and medical staff because security staff are 
required to accompany prisoners to medical appointments.
Concerns about personal risk
A recurring theme throughout the focus groups was concern 
for personal safety. This concern covered the areas of personal 
safety and risk of exposure to, and acquisition of, blood-
borne viruses, including HCV. Prison officers described a work 
environment of increasing inter-prisoner violence and severity 
of assault often leading to open wounds and blood loss.
Lack of knowledge
Lack of knowledge among staff was recognised as a major 
barrier to HCV screening and treatment. Participants identified 
the provision of education and training as a means of 
addressing this knowledge deficit. All grades of staff felt a lack 
of knowledge in relation to the newer HCV treatments and the 
risks of transmission impacted on their ability to engage with 
prisoners on this issue. Participants also identified the lack of 
knowledge among prisoners as a barrier to HCV treatment; 
in particular, the inaccurate information being circulated 
regarding the side-effects of treatment, which were historical 
and associated with interferon-based treatment.
Concerns regarding confidentiality
Prison officer participants reported that lack of confidentiality 
was a barrier to HCV screening and treatment. Often breaches 
in confidentiality were inadvertent and were related to 
prisoners being called to attend certain clinics that were 
connected with HCV, addiction treatment or HIV care. A 
number of officers felt that if issues regarding confidentiality 
were addressed that more prisoners would approach prison 
officers to discuss HCV-related concerns and that this might be 
a resource to educate prisoners on HCV-related issues.
Prisoners’ fear of treatment and stigma
A number of participants identified fear of treatment as 
a barrier to prisoners engaging with health services. Fear 
of treatment was linked to the side-effects of interferon 
treatment, liver biopsy, and the concerns about stigma. It was 
suggested that making screening routine or opt-out had the 
potential to reduce stigma.
Time of screening
Both prison officer and governor participants favoured a 
structured and systematic approach to HCV screening. The 
committal period was identified by all groups as an opportune 
time to engage prisoners with health services and provide HCV 
screening. Some prison officers identified other time periods 
that might be suited to HCV screening. They described ‘down 
times’ within the week where routine work was not scheduled 
and that health-related programmes provided during these 
times might have the added benefit of relieving boredom for 
prisoners.
Peer workers
Participants in all focus groups agreed that trained peer 
workers had the potential to facilitate prisoner engagement 
with health services, including HCV screening and treatment. 
The narrative around peer workers included prisoners having 
more trust in their peer networks than ‘The System’.
In-reach hepatology and fibroscanning services
The availability of in-reach hepatology and mobile elastography 
were seen as enablers to prisoner engagement in HCV care. In 
particular, the cost-effectiveness and staff-saving benefits of 
in-reach services were viewed by the governor focus groups as 
a major benefit. The reduction of risk associated with prisoners 
having to attend hospital services was also noted.
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Conclusions
The authors noted that although Irish prisons are a key setting 
to identify and treat HCV-infected PWID, this can only be 
achieved by the elimination of identifi ed barriers to HCV 
screening and treatment in Irish prisons. In particular, they 
suggest that upscaling HCV management in prisons requires 
an in-depth understanding of all barriers and facilitators to 
HCV screening and treatment. Engaging prison offi  cers in the 
planning and delivery of healthcare initiatives may be a key 
strategy to optimising the public health opportunity that prison 
provides.
Hepatitis C virus screening and 
treatment in Irish prisons   continued
Deaths in custody in 
Irish prisons
In 1997, it was observed that prison suicide patterns in Ireland 
mirrored those in neighbouring jurisdictions and that numbers 
had increased markedly over the previous 10 years.1 A 1999 
report noted that although most deaths were judged to be 
suicides, there had been an increase in deaths due to drug 
overdoses.2 A systematic survey of mental health in Irish prisons 
found that 69% of prisoners reported signifi cant substance 
or alcohol misuse issues prior to committal.3 In order to plan 
preventive measures, an investigation was commissioned by the 
National Suicide and Harm Prevention Steering Group to review 
the deaths of prisoners in Ireland between 2009 and 2014.4
Coroners’ fi ndings were analysed, including postmortem tests, 
to assess whether drugs played a role or not.
In all, there were 69 deaths in custody over this period, of 
which 38 were deemed to be not from natural causes. Sixteen 
cases involved drug overdoses. Another eight deaths, all due 
to hanging, were linked to drug taking. Drug tests showed that 
two other deaths were also associated with the use of drugs. 
The drugs involved in the deaths included non-prescribed 
benzodiazepines, opiates, cocaine, cannabis, codeine, and 
other psychoactive substances. Many also had alcohol and 
prescription drugs in their system.
The investigation noted that 14 of the 38 prisoners died while 
on temporary release, suggesting that imprisonment may off er 
partial protection and that continuity of care post-release is 
crucially important. The study authors suggest that friends 
and family members who visit prisons should be made aware 
that bringing in contraband is a major contributory factor to 
unnatural deaths in custody, including deaths by hanging.
Seán Millar
1 Dooley E (1997) Prison suicide – politics and prevention: a view 
from Ireland. Crisis, 18(4): 185–90.
2 Department of Justice (1999) Report of the National Steering 
Group on Deaths in Prisons. Dublin: Stationery Offi  ce. https://
www.drugsandalcohol.ie/5391/
3 Kennedy HG, Monks S, Curtin K, Wright B, Linehan S, Duff y D, et 
al. (2005) Mental illness in Irish prisoners: psychiatric morbidity 
in sentenced, remanded and newly committed prisoners. 
Dublin: National Forensic Mental Health Service. https://www.
drugsandalcohol.ie/6393/
4 Iqtidar M, Sharma K, Mullaney R, Kelly E, Keevans M, Cullinane M, 
et al. (2018) Deaths in custody in the Irish prison service: 5-year 
retrospective study of drug toxicology and unnatural deaths. 
BJPsych Open, 4(5): 401–03. https://www.drugsandalcohol.
ie/30871/
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Irish prisoner population. Dublin: National Advisory Committee 
on Drugs and Alcohol (NACDA). https://www.drugsandalcohol.
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3 Allwright S, Bradley F, Long J, Barry J, Thornton L and Parry 
JV (2000) Prevalence of antibodies to hepatitis B, hepatitis C, 
and HIV and risk factors in Irish prisoners: results of a national 
cross sectional survey. Br Med J, 321(7253): 78–82. https://www.
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4 Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS and 
Cullen W (2018) Hepatitis C virus screening and treatment in 
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qualitative exploration. Health & Justice, 6(1): 23. https://www.
drugsandalcohol.ie/30873/
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19 Self-harm in Irish 
prisons
There are 12 institutions in the Irish prison system, comprising 
10 traditional ‘closed’ institutions and two open centres, 
which operate with minimal internal and perimeter security. 
The majority of female prisoners are accommodated in the 
purpose-built Dóchas Centre adjacent to Mountjoy Prison in 
Dublin, while the remainder are located in a separate wing of 
Limerick Prison. Self-harm and suicide are major issues in the 
prison population, as rates of suicide and lifetime self-harm 
are higher in prisoners compared with the general population. 
The rate of suicide in Irish prisons from 2011 to 2014 was 47 
per 100,000 prisoners. However, to date, research on suicidal 
behaviour in Irish prisons has been limited. 
The Self-Harm Assessment and Data Analysis (SADA) Project has 
been set up in Ireland to provide robust information relating 
to the incidence and profile of self-harm within prison settings 
as well as individual- and context-specific risk factors relating 
to self-harm; and to examine patterns of repeat self-harm 
(both non-fatal and fatal). The Health Service Executive’s 
National Office for Suicide Prevention and the National Suicide 
Research Foundation assist the Irish Prison Service with data 
management, data analysis, and reporting. This article highlights 
findings from a report1 detailing the first 12 months of data on 
the analysis of all episodes of self-harm across the Irish prison 
estate in 2017.
Episodes
Between 1 January and 31 December 2017, there were 223 
episodes of self-harm recorded in Irish prisons, involving 138 
individuals. The majority of prisoners were male (80%) and the 
mean age was 32 years. The annual person-based rate of self-
harm was 4.0 per 100 prisoners. Thus, an episode of self-harm 
was recorded for 4% of the prison population. Compared with 
sentenced prisoners, the rate of self-harm was 2.4 times higher 
among prisoners on remand (7.4 vs 3.1 per 100), while the rate 
of self-harm was highest among prisoners aged 18–29 years, at 
5.0 per 100 prisoners. Episodes of self-harm were more likely 
to occur on weekdays, with one in five (22%) episodes occurring 
on Tuesdays. More than one-half of episodes (52%) occurred 
between 2pm and 8pm and a majority of episodes (60%) 
occurred while prisoners were unlocked from cells. Twenty-six 
per cent of male prisoners repeated self-harm compared with 
16% of female prisoners.
Methods, severity and intent
The most common method of self-harm recorded was self-
cutting or scratching, which was present in 62% of all episodes. 
The other common method of self-harm was attempted 
hanging, which was involved in 21% of episodes. Methods of 
self-harm were similar for male and female prisoners. In 39% 
of self-harm episodes, no medical treatment was required 
(n=87), while almost one-half (102; 45.7%) of all episodes 
required minimal intervention/minor dressings or local 
wound management. One in eight episodes required hospital 
treatment (30; 13.5%) and four self-harm acts involved loss of 
life (1.8%).
One-half (121; 54.3%) of self-harm episodes were recorded 
as having no/low intent, with less than one-third (65; 29.1%) 
recorded as having medium intent. Approximately, one in six 
acts was rated as having high intent (37; 16.6%). Suicidal intent 
varied according to the method involved in the self-harm 
episode; high intent was recorded in more than two-thirds of 
attempted hanging episodes (17; 37.0%).
Contributory factors
The most common contributory factors to self-harm are shown 
in Figure 1. The majority of contributory factors recorded 
related to mental health (129; 57.8%) and a further 84 (37.7%) 
related to relational issues and 81 (36.3%) to environmental 
issues. The category of mental health issues included mental 
disorders as well as problems with coping and emotional 
regulation. Substance misuse, including drug use as well as 
drug seeking, was the next most common factor recorded (51; 
22.9%). Hopelessness was recorded as a contributory factor in 
6.3% and active psychosis/mental illness in 4.5% of self-harm 
episodes.
Other findings
Other findings highlighted in the report include the following:
• Three-quarters (77%) of self-harm episodes involved 
prisoners in single cell accommodation. 
0
Mental health issues
Substance misuse
Type of accommodation
Recent cell move
Relationship difficulties with staff
Relationship difficulties with partner/family/friends
Legal issues
5
Percentage (%)
10 15 20 25 30 35 40 45
Figure 1: Most common contributory factors to self-harm in Irish prisons, 2017
Source: Griffin et al., 2018
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Self-harm in Irish prisons   continued
In June 2019, the collective restorative justice strategy for 
Ireland was published.1 The strategy is the first Irish output of 
a four-year, collaborative cross-European project aimed at 
helping to embed restorative justice and restorative practices 
within the Irish criminal justice system.
So, what is restorative justice? The concept has been achieving 
increased support within criminal justice jurisdictions in many 
countries for several years. Notably, in Ireland, the idea first 
emerged in the 1970s, while the practice has been in operation 
on a statutory basis under the Children Acts 2001–2015 and, 
Table 1: Key questions regarding restorative justice in Ireland 
Restorative justice in Ireland: key questions
What is restorative 
justice?
Restorative justice is defined by the Criminal Justice (Victims of Crime) Act 2017 in Ireland as ‘any 
scheme administered for the time being under which, with the consent of each of them, a victim and 
an offender or alleged offender engage with each other to resolve, with the assistance of an impartial 
third party, matters arising from the offence or alleged offence’ (S.2(1)).4 This definition is broadened 
by the Council of Europe Recommendation, which defines it as ‘any process which enables those 
harmed by crime, and those responsible for that harm, if they freely consent, to participate actively 
in the resolution of matters arising from the offence, through the help of a trained and impartial third 
party’.5
What are restorative 
practices?
The approach used to shape and maintain interpersonal relationships, resolve conflict, and mend 
broken relationships is known as restorative practice.6 In the context of this project, it refers to the 
use of a restorative framework within the criminal justice system (CJS). It considers how people 
who work within or with the CJS interact with each other and the community. In addition, the term 
represents the approaches used to develop relationships, share information, and establish more 
comprehensive decision-making processes.
Who can participate in 
restorative justice?
Restorative justice is usually carried out between victims and offenders when it is deemed to be in 
the best interests of both parties.1 The type and circumstances of the offence are also considered. 
Participation in the process is assessed by trained professionals on a case-by-case basis.
When can restorative 
justice be used?
Restorative justice can be used at all stages of the criminal justice process, for example, as a means 
of diversion, at pre-sentence and post-sentence stages to assist and support victim recovery, and 
to manage, rehabilitate and reintegrate offenders, and prevent crime.1 Notably, it should not be used 
instead of a prosecution, in relation to more serious cases; the public interest demands that it should 
only run in parallel or after a prosecution.
Is restorative justice 
always the same?
How restorative justice is implemented varies and is dependent on several factors: preparation 
involved (nature, extent, and dynamics), practice, and follow-up needed. Hence, how it is applied 
in a serious crime involving violence will differ from an acquisitive offence, such as shoplifting or 
theft. In addition, careful assessment of vulnerability levels, trauma, and mental health experienced 
will contribute to the decision of how or if restorative justice should take place (p. 4).1 Practitioners 
should have the experience and training that qualifies them to work with the circumstances and 
vulnerabilities that are presented.
How does this work 
relate to other 
sectors?
Although this project is centred specifically on the CJS, the authors believe that this work will 
complement similar work that is being carried out in other areas in Ireland, such as local communities, 
workplaces, education, and social care settings.
Source: Restorative justice: strategies for change, 2019, pp. 3–4.
• While 44% of prisoners who engaged in self-harm were in 
general population accommodation, a further 44% were in 
protection at the time of the self-harm act.
• The four fatal episodes of self-harm involved male 
prisoners who were on remand. Multiple contributory 
factors were associated with these deaths.
Seán Millar
1 Griffin E, Cully G, Corcoran P, Hume S, Kelly E and O’Reilly D (2018) 
Self-harm in Irish prisons 2017. First report from the Self-Harm 
Assessment and Data Analysis (SADA) Project. Cork: National 
Suicide Research Foundation. https://www.drugsandalcohol.
ie/29772/
RESPONSES
Restorative justice – strategies for change
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more recently, under the Criminal Justice (Victims of Crime) 
Act 2017.2,3,4 Table 1 presents a summary of key questions that 
arise regarding restorative justice in Ireland.1
Strategy background
The idea for the strategy arose from discussions between 
restorative justice scholars, policymakers, and practitioners 
attending the 10th International Conference of the European 
Forum for Restorative Justice (EFRJ) in Tirana, Albania in June 
2018.1 Dr Ian Marder, Gert Jan Slump of Restorative Justice 
Nederland, and representatives of the EFRJ, Tim Chapman, Dr 
Bart Claes and Edit Törz, agreed to act as project partners. The 
agreed purpose for the project was to:
• Contribute towards refocusing European criminal 
justice systems, agencies, policies, and practices around 
restorative principles and processes
• Determine how the Council of Europe Recommendation 
CM/Rec(2018)8 concerning restorative justice in criminal 
matters could be used to support this work.
To achieve these aims, four core members were appointed in 
Ireland and nine other participating European jurisdictions: 
Albania, Belgium, Czechia, Estonia, Italy, the Netherlands, 
Poland, Portugal and Scotland. Core members in each area 
mainly come from academia, justice departments, criminal 
justice agencies, and non-governmental organisations 
(NGOs). Ireland’s core members are Dr Ian Marder (Maynooth 
University); Ursula Fernée (Restorative Justice and Victim 
Services Unit, Probation Service); Tim Chapman (Ulster 
University); and Dr Kieran O’Dwyer (Kennedy Institute 
Peacebuilding Group). Core members have been in place since 
January 2019 and the project is expected to last four years.
Strategic pillars
The collective strategy for Ireland is centred on information 
collected from attendees at the Restorative Justice: Strategies 
for Change Symposium (n=94) at Maynooth University in March 
2019.1 People and stakeholders who were unable to attend 
were also given an opportunity to contribute information by 
email. Three strategic pillars for the strategy were identified 
and formed the basis of the final report (see Table 2). An outline 
of the main objectives and potential actions for each pillar is 
presented in the strategy.1
Restorative justice   continued
Steps to implementation 
On 4 June 2019, the authors began the process of disseminating 
the strategy. They requested that all those on the Stakeholder 
Group (or who otherwise have an interest in, or responsibility 
for, the development and use of restorative justice in the Irish 
CJS) assist them in doing so by publishing the strategy on their 
organisational websites, mentioning it in their newsletters, and 
circulating and discussing it widely among colleagues.
They are currently designing the process by which, in 
collaboration with the Stakeholder Group and with other 
stakeholders, they will devise and implement specific actions 
that contribute to achieving the objectives outlined under each 
strategic pillar. If anyone would like to join the Stakeholder 
Group, please email Dr Ian Marder (ian.marder@mu.ie) with 
your name, role and organisation.1
Ciara H Guiney
1 Marder I, Fernée U, Chapman T and O’Dwyer K (2019) Restorative 
justice: strategies for change – a collective strategy for Ireland, 
2019–2023: research report. Maynooth: Maynooth University. 
https://www.drugsandalcohol.ie/30686/
2 National Commission on Restorative Justice (2008) National 
Commission on Restorative Justice: Interim report. Dublin: 
National Commission on Restorative Justice. Available online at: 
http://www.justice.ie/en/JELR/RestorativeJustive%20LR.pdf/
Files/RestorativeJustive%20LR.pdf
3 National Commission on Restorative Justice (2009) National 
Commission on Restorative Justice: Final report. Dublin: National 
Commission on Restorative Justice. Available online at: http://
www.justice.ie/en/JELR/NCRJ%20Final%20Report.pdf/Files/
NCRJ%20Final%20Report.pdf
4 Criminal Justice (Victims of Crime) Act 2017. Available online at: 
http://www.irishstatutebook.ie/eli/2017/act/28/enacted/en/html
5 Council of Europe (2018) Recommendation CM/Rec(2018)8 
of the Committee of Ministers to member states concerning 
restorative justice in criminal matters. Strasbourg: Council of 
Europe. Available online at: https://search.coe.int/cm/Pages/
result_details.aspx?ObjectId=09000016808e35f3
6 O’Dwyer K (2014) Towards excellence in restorative practice: a 
quality assurance framework for organisations and practitioners. 
Dublin: Restorative Practices Strategic Forum. Available online 
at https://www.cdi.ie/wp-content/uploads/2016/11/RPSF_QA_
Framework_FINAL.pdf
Table 2: Strategic pillars of the restorative justice strategy 
No Strategic pillar Statement of principle
1 Accessibility Safe, high-quality restorative justice should be available to all victims and offenders who would 
benefit from participation. Access should not depend, exclusively and in the absence of other 
considerations, on where they live in Ireland, their age, the offence in question, or the stage of 
the criminal justice process. Other affected persons should also be enabled to participate in 
restorative justice, if victims and offenders so wish.
2 Knowledge Restorative justice should be known and understood widely enough and to such an extent that 
all relevant persons are aware of its potential benefits and risks, and the available services.
3 Cultural change All persons working in or in collaboration with the criminal justice system should be trained in 
restorative practices so that they are confident in using these skills, principles and processes in 
their day-to-day work. This will help support the development of more responsive, relational, 
participatory, procedurally just and reflective organisational cultures.
Source: Restorative justice: strategies for change, 2019, pp. 5–8
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Addressing 
educational 
disadvantage – 
Youthreach and DEIS
Educational disadvantage is widely recognised as a risk factor 
for substance misuse.1 Improving supports for young people 
at risk of early substance use is an action of the national drugs 
strategy – Reducing harm, supporting recovery: a health-led 
response to drug and alcohol use in Ireland 2017-2025 (Action 
1.2.5),2 which identifies the preventative role of programmes 
that support young people to stay in education. The 
Government funds several programmes in this area and two of 
its key programmes have recently been evaluated:
• Youthreach: Evaluation of the National Youthreach 
Programme1
• Delivering Equality of Opportunity in Schools (DEIS): 
The evaluation of DEIS at post-primary level: closing the 
achievement and attainment gaps.3
PROGRAMME 1: Youthreach
Youthreach is the Irish Government’s primary response to early 
school-leaving. It aims ‘to provide early school leavers (16–20 
years) with the knowledge, skills and confidence required to 
participate fully in society and progress to further education, 
training and employment’ (p. 9).4 It is described as not only 
having a focus on progression to education and training but also 
plays a role in facilitating social inclusion (p. xi).1 The programme 
has been the subject of an in-depth evaluation, whose findings 
were published in June 2019 in Evaluation of the National 
Youthreach Programme.1
Youthreach provides what is described as ‘second-chance 
education’ for those who have left mainstream second-level 
school before Leaving Certificate level (p. xi). It is delivered 
in two settings that have their own distinct governance and 
funding structures: Youthreach centres, of which there are 112 
nationally; and Community Training Centres, of which there are 
35 nationally. Centres vary in what they offer learners. While 
QQI Levels 3 and 4 are the most common courses offered, 
some provide Level 2 courses and the Leaving Certificate 
Applied programme. A small number offer the Junior 
Certificate and the Leaving Certificate. In 2017, some 11,104 
learners took part in the programme (p. xi).
Methods
The evaluation takes a mixed methods approach, combining 
quantitative and qualitative data gathered from a range of 
stakeholders. This approach enables the evaluators to assess 
the programme’s effectiveness and reflect the multiple 
challenges being faced by young people involved with the 
programme, for example, socioeconomic disadvantage and 
special educational needs. Furthermore, the approach 
captures the range of outcomes being achieved by a 
programme which promotes the development of a broad set of 
skills among young people, with an emphasis on personal and 
social development.
The evaluation team carried out surveys of senior managers 
at Education and Training Board level, centre coordinators 
and managers; and in-depth case studies of 10 centres, 
which involved qualitative interviews with staff, coordinators/
managers, and current and former learners. They emphasise 
the importance of capturing young people’s voices through 
the evaluation; they describe the interviews with young people 
as having yielded new insights into their pathways into the 
programme, their experiences of Youthreach, and the impact 
they feel it has had on them.
Selection of findings
The report is highly detailed and explores all aspects of the 
programme, including the profile of learners; referral to the 
programme; governance and reporting structures; programme 
funding and resources; curriculum; approaches to teaching and 
learning; and learner experiences and outcomes. It is beyond 
the scope of this article to provide a detailed description of 
the full range of findings; however, a selection of key findings is 
provided here.
Increased marginalisation
While there has been a notable decline in the number of 
early school-leavers in Ireland since 2009, this group was 
found to have become ‘more marginalised in profile’ (p. 205) 
over time. What is described as a ‘striking finding’ (p. 205) is 
that young people are presenting to Youthreach with greater 
levels of need, with increased prevalence of mental health 
and emotional problems as well as learning difficulties. Among 
the challenges faced was substance misuse – both that of 
young people themselves and that of a family member. This 
concentration of complex needs was found to have implications 
for the kind of support required by learners and the staff skill 
set necessary to meet these needs.
Programme aims and outcome measurements
Senior managers and coordinators adopted a holistic view of 
the programme aims. While there was some variation between 
groups of stakeholders, overall they perceived the programme 
as having multiple aims, including re-engaging young people 
in learning; providing a positive learning experience; fostering 
the development of personal and social skills, the acquisition 
of qualifications, and progression to education, training and 
employment. Given this broad perspective, they were largely 
critical of the current system in which the programme’s 
metrics only capture the aims of the programme in terms of 
progression to education, training, and employment.
Course content and learning
As mentioned above, centres varied in the courses and 
qualifications they offered. While this was in part attributed 
to governance structures, the findings overall indicated 
that centres tailored provision to learner needs. As well as 
accredited courses provided by Quality and Qualifications 
Ireland (QQI) and the State Examinations Commission, the 
vast majority also offered other activities to meet the needs 
of their learners. Among these were ‘courses and talks around 
drug awareness’ (p. 209). Overall, learners were very positive 
about their Youthreach learning experiences, especially when 
compared with their experience of mainstream education.
Additional supports
Given the needs profile of Youthreach learners, providers 
offered a range of other supports for learners. These included 
work placement, career guidance, personal counselling, and 
informal support from staff. The evaluation found that central 
to this was the quality of relationships with staff and other 
young people. Learners reported that the support, respect, and 
care they received from centre staff were critical.
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Outcomes
Evidence on outcomes was reported through the routine 
monitoring system for Youthreach (SOLAS FARR database), 
the study surveys, and qualitative interviews. Findings from 
the quantitative indicators of outcomes included that, for 
2017, the SOLAS FARR database indicated non-completion 
rates of 14% across the programme; for the same year, the 
accreditation rate for both full and component awards was 
42%. When comparing the number of awards with the number 
of learners (using survey data from coordinators and managers), 
an estimated 60% of those completing the programme 
received a full award. Also, according to the survey data, 45% 
of completers progress on to another education or training 
course; 43% go straight into the labour market; and one in six 
completers are unemployed (pp. 211–12).
Positive outcomes related to the development of personal 
and social skills as well as enhancement of emotional 
wellbeing were also reported. For example, learners identified 
improvements in their engagement with learning, increased 
self-confidence, and the development of ‘a purpose in life and 
hope for the future’ (p. 212). As mentioned above, there was 
heavy criticism of these outcomes not being captured through 
routine monitoring systems.
Conclusion
Overall, the study findings indicate that the programme works 
well as second-chance provision for often vulnerable young 
people with complex needs.
[It offers a] positive experience of teaching 
and learning, fostering personal and social skill 
development, and equipping many with certification 
to access further education, training and employment 
options …. providing courses and approaches tailored 
to their needs, and embedding education/training 
provision within a broader network of supports. (p. xvii)
PROGRAMME 2: DEIS
Delivering Equality of Opportunity in Schools (DEIS) is the 
Department of Education and Skills’ policy instrument to 
address educational disadvantage, which was launched in 2005. 
It aims to improve attendance, participation, and retention in 
designated schools located in disadvantaged areas. A range 
of supports is provided to participating schools; for example, 
a lower pupil–teacher ratio in some schools; access to the 
Home School Community Liaison Scheme; the School Meals 
Programme; and literacy and numeracy supports.
The programme has been the subject of a number of reports, 
the most recent of which is The evaluation of DEIS at post-
primary level: closing the achievement and attainment gaps, 
published in late 2018 by the Educational Research Centre.3  
The report looks at achievement and retention in DEIS and 
non-DEIS schools at post-primary level.
Key findings
Overall achievement
Between 2002 and 2016, there was a narrowing of the gap in 
Junior Certificate examination (JCE) achievement between 
DEIS and non-DEIS schools, as measured by the overall 
performance scale (OPS).5 The average annual rate of increase 
in non-DEIS schools from 2002 to 2016 was 0.19 OPS points, but 
was significantly higher (p<0.001) for DEIS schools, at an average 
increase of 0.33 OPS points per year (see Figure 1). What this 
means in terms of grades (A–E) is that DEIS schools saw an 
increase over the period that was equivalent to an approximate 
increase of one letter grade. A similar increase was not found 
in non-DEIS schools. The overall gap in OPS reduced from 
10.5 points in 2002 to 4.6 in 2016. When looking at two specific 
subjects, a narrowing of the gap was also found for English and 
mathematics. 
Retention
The study found a significant upward trend in both Junior Cycle 
and Senior Cycle retention for the entry cohorts between 1995 
and 2011 across all schools. Those entering 1st Year in 1995 had 
a Junior Cycle retention rate of 94.3%, which had increased 
to 97.1% for the 2011 cohort. For the same period, the Senior 
Cycle retention rate increased from 77.3% to 90.2%. Despite 
a narrowing of the gap, there continues to be sizeable gaps in 
retention between DEIS and non-DEIS schools in both cycles. 
For the 1995 cohort, there was an 8.6 percentage point gap for 
Junior Cycle, which had reduced to 2.2 percentage points for 
the 2011 cohort. For Senior Cycle, there was a 22.1 percentage 
point gap for the 1995 cohort; for the most recent cohort, it 
was 11 percentage points.
Medical card possession and achievement
In both DEIS and non-DEIS schools, gaps existed between the 
average achievements of students from medical card-holding 
families and those from families without medical cards; those 
without medical cards outperformed those with medical cards.
Social context effect
The authors explored whether there was a ‘social 
context effect’ on student achievement. They tested the 
hypothesis that increasing concentrations of students from 
socioeconomically disadvantaged backgrounds would have a 
negative impact on individual student achievement, irrespective 
of that individual’s own socioeconomic background. The two 
student-level variables on which data were available – gender 
and medical card possession – explained 31% of the between-
school variance in English and mathematics achievement in 
2016. The addition of the measure of social context, that is, the 
percentage of students from medical card-holding families in 
a school, explained an additional 40% of the between-school 
variance in English achievement and an additional 42% of 
the between-school variance in mathematics achievement 
in 2016. This indicates a clear social context effect – the 
impact of being a student in a school with concentrations of 
other socioeconomically disadvantaged backgrounds has a 
substantial negative impact on achievement, regardless of 
whether a student has a medical card themselves or not.
Final comment
The report is descriptive of changes over time and illustrates a 
narrowing of the gap between DEIS and non-DEIS schools. As 
suggested by the authors, the findings on medical cards and 
the social context effect suggest support for policies that target 
resources at schools with concentrations of students from 
socioeconomically deprived backgrounds. However, the report 
is limited in its inability to conclude whether or not the changes 
found are attributable to the DEIS programme. As with previous 
DEIS reports, a key limitation is that a control group is not used; 
therefore, it cannot be established with any certainty whether 
improvements are due to the programme or to improvements 
that would have happened anyway.
Addressing educational 
disadvantage   continued
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Figure 1: Average OPS score in the Junior Certificate examination from 2002 to 2016 in all schools, DEIS schools, and non-DEIS schools*
Source: Weir and Kavanagh, 2018, p. 83
* OPS data for 2004 were not available to the authors.
Lucy Dillon
1 Smyth E, Banks J, O’Sullivan J, McCoy S, Redmond P and 
McGuinness S (2019) Evaluation of the National Youthreach 
Programme. Dublin: Economic and Social Research Institute. 
https://www.drugsandalcohol.ie/30687/
2 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 2017-
2025. Dublin: Department of Health. https://www.drugsandalcohol.
ie/27603/
3 Weir S and Kavanagh L (2018) The evaluation of DEIS at post-
primary level: closing the achievement and attainment gaps. 
Dublin: Educational Research Centre. Available online at:
 https://www.education.ie/en/Schools-Colleges/Services/DEIS-
Delivering-Equality-of-Opportunity-in-Schools-/the-evaluation-
of-deis-at-post-primary-level-closing-the-achievement-and-
attainment-gaps.pdf
4 Department of Education and Skills (DES) (2015) Operator 
guidelines for the Youthreach programme. Dublin: DES.
5 OPS is a tool in which a numerical value is attached to each of the 
alphabetical grades (A–E) awarded to JCE candidates for each 
subject; summing these values produces an index of a candidate’s 
general scholastic achievement across their seven best subjects. 
These are then aggregated to produce an index of achievement in 
the JCE at a school level.
Addressing educational 
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report, 2018
The Tabor Group is a provider of residential addiction 
treatment services in Ireland. It aims to offer hope, healing, and 
recovery to clients suffering from addictions through integrated 
and caring services. In addition to three residential facilities, 
the organisation provides a continuing care programme to 
clients who have completed treatment in order to assist with 
their recovery. It also offers counselling to families whose loved 
ones are struggling with an addiction. In 2019, the Tabor Group 
published its annual report.1 This article highlights services 
provided by the Tabor Group to individuals with a substance 
use addiction in 2018.
Tabor Lodge: residential addiction treatment 
centre
Tabor Lodge is a residential addiction treatment centre for 
people addicted to alcohol, drugs, gambling, and food. It is 
situated 15 miles south of Cork city. Tabor Lodge is guided 
by the Minnesota Model of addiction treatment in delivering 
its treatment programme. This model is characterised by the 
understanding that addiction is primarily a substance use 
disorder. The primary focus of the treatment programme is 
to educate clients on the dynamics of this disorder as they 
manifest in the life of the individual. Another important focus of 
the treatment programme is to assist clients develop the skills 
necessary to manage their disorder while going forward in their 
lives.
A total of 222 clients (72% male) were admitted to Tabor Lodge 
for residential treatment of addiction in 2018, of whom 208 
completed treatment. A breakdown of the specific drug of 
choice for admissions in 2018 is shown in Table 1. The clinical 
staff at Tabor Lodge have observed a changing profile of clients 
presenting for treatment in recent years, with mental health 
challenges and a history of childhood trauma becoming more 
evident. With this in mind, staff at Tabor Lodge have become 
more informed about childhood trauma as a contributing 
factor to the development of addiction, and as a hindering 
factor in efforts to manage addiction disorders. In 2017, 
Tabor Lodge responded to the greater prevalence of clients 
presenting for treatment with a history of childhood trauma by 
initiating a training programme. This is to ensure that services 
at Tabor Lodge become more ‘trauma informed’, as an agency 
treating adults vulnerable to the ongoing debilitating impact of 
childhood trauma.
Fellowship House: men’s residence extended 
treatment centre
The extended treatment programme for men is based on the 
Hazelden Minnesota Model and promotes ‘total abstinence’. The 
aim is to build on and consolidate the work of recovery already 
begun in primary treatment – even if that treatment was not in 
the recent past and the client is struggling to maintain sobriety.
In 2018, some 34 clients were admitted to Fellowship House 
for extended treatment; a total of 18 individuals completed the 
programme. A breakdown of the specific drug of choice for 
admissions to Fellowship House in 2018 is shown in Table 2. The 
report observed that cannabis and cocaine remain high at 82%, 
with 94% of clients reporting alcohol as their specific drug of 
choice.
Table 1: Specific drug of choice for clients admitted to Tabor Lodge: 
residential addiction treatment centre, in 2018 
Drug of choice Number of 
clients
Percentage of 
clients (%)
Opiates 12 5
Cocaine 29 13
Cannabis 12 5
Alcohol 148 67
Stimulants 1 0.5
Hypnotics and 
sedatives
10 5
Other substances 2 1
Source: Tabor Group, 2019
Table 2: Specific drug of choice for clients admitted to Fellowship 
House: men’s residence extended treatment centre, in 2018 
Drug of choice Number of 
clients
Percentage of 
clients (%)
Alcohol 32 94
Ecstasy 25 74
Cannabis 28 82
Cocaine 28 82
Prescribed 
medication
26 76
Heroin 9 26
Methadone 4 12
Speed 21 62
LSD 18 53
Other/Headshop 10 29
Source: Tabor Group, 2019
Renewal: women’s residence extended 
treatment centre
Renewal works with women who have completed a primary  
28-day treatment programme. It is a 12-week residential 
extended treatment programme, where clients learn to find 
routine, balance, and structure. Renewal is the only Minnesota 
Model extended treatment centre for women based in Ireland 
and was opened in 1999.
In 2018, some 51 clients were admitted to Renewal, of which 
30 completed the programme. Seventy per cent of these 
clients were aged between 18 and 35 years. A breakdown 
of the specific drug of choice for admissions to Renewal in 
2018 is shown in Table 3. In this year, 90% of clients admitted 
presented with a history of alcohol abuse.
In addition to group therapy, lectures and one-to-one 
counselling, the programme at Renewal also arranges family 
conferences, which help clients to reconnect with their families 
as well as educating families about addiction and offering them 
support. The programme also works in partnership with Tusla, 
the Child and Family Agency, as many women have children in 
care and need help reconnecting and rebuilding the parent/
child relationship.
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Tabor Group annual report, 2018 
continued
Table 3: Specifi c drug of choice for clients admitted to Renewal: 
women’s residence extended treatment centre, in 2018 
Drug of choice Number of 
clients
Percentage of 
clients (%)
Alcohol 46 90
Ecstasy 33 65
Cannabis 35 69
Cocaine 35 69
Prescribed 
medication
37 73
Heroin 13 25
Methadone 9 18
Speed 26 51
LSD 15 29
Other/Headshop 4 8
Source: Tabor Group, 2019
Conclusions
The Tabor Group observed that the number of people 
presenting with opiate or heroin addiction was down from 8% 
in 2017 to 5% of all presentations in 2018. However, cocaine 
use among all clients presenting for treatment has more than 
trebled since 2016 – up from 4% to 13% – with cannabis also 
up 1% in the past year. In addition, addiction to alcohol alone 
is seen rarely, according to the report, with large numbers of 
people presenting for treatment indicating polydrug use, with 
ecstasy, cannabis, cocaine, heroin, and prescribed medication 
being reported.
Seán Millar
1 Tabor Group (2019) Tabor Group annual report 2018. Cork: Tabor 
Group. https://www.drugsandalcohol.ie/30698/
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UPDATES
Recent publications
PREVALENCE AND CURRENT SITUATION
Mapping service user needs to inform a supervised injecting 
room location in Cork, Ireland
Horan JA and Van Hout MC (2019) Heroin Addiction and Related 
Clinical Problems, Early online.
https://www.drugsandalcohol.ie/30540/ 
The aim of the study was to map the location of current injecting 
practices of people who inject drugs (PWID) in Cork, Ireland, and 
to document the related high-risk behaviours, ahead of a planned 
supervised injecting facility [SIF].
The study provides an understanding of PWID profile and risk 
behaviours, alongside a geospatial analysis of injecting, overdose 
and potential location of a SIF in Cork, Ireland. The findings 
are intended to inform SIF location, and would allow dynamic 
comparison of both geographic and behavioural changes injecting 
drug use over time, post SIF provision.
Making sense of street chaos: an ethnographic exploration of 
homeless people’s health service utilization
O'Carroll A and Wainwright D (2019) International Journal for 
Equity in Health, 18(113).
https://www.drugsandalcohol.ie/30847/ 
Homeless people have poor health and mortality indices. Despite 
this they make poor usage of health services. This study sought 
to understand why they use health services differently from the 
domiciled population.
An explanatory critical realist model integrating the identified 
generative mechanisms, external and internalised barriers was 
developed to explain why the health service utilization of homeless 
people differs from the domiciled populations. This new model has 
implications for health service policy makers and providers in how 
they design and deliver accessible health services to homeless 
people
National Drugs Library
Longitudinal social network analysis of peer, family, and school 
contextual influences on adolescent drinking frequency
McCann M, Jordan J-A, Higgins K and Moore L (2019) Journal of 
Adolescent Health, 65(3): 350–358.
https://www.drugsandalcohol.ie/30795/ 
The aim of the study was to identify the mechanisms relating to 
parental control, adolescent secrecy, and school context that 
shape patterns of adolescent drinking frequency and appraise the 
implications for systems-level intervention.
Our results suggest that the optimal strategy for selecting seed 
nodes in a diffusion of innovations network intervention may 
vary according to school context, and that targeting family 
interventions around parent characteristics may modify the wider 
school network, potentially augmenting network intervention 
processes.
A psychoactive paradox of masculinities: cohesive and 
competitive relations between drug taking Irish men
Darcy C (2019) Gender, Place & Culture, Early online.
https://www.drugsandalcohol.ie/30766/ 
This article explores one dimension of Ireland’s illicit drug 
landscape: men’s predominance as recreational users of illicit 
psychoactive substances. It uses a gender lens on Irish men’s 
drug taking practices, to reveal how men’s drug use and drug 
intoxication converge with masculinities in paradoxical ways.
By employing a masculinities lens to analyse men’s recreational use 
of illicit psychoactive substances, men’s drug taking interactions 
reveal intricacies within the gender order. I argue that illicit drugs 
are resources that some men utilise to navigate conventional 
understandings of masculinity, albeit in paradoxical ways.
Cognitive performance and mood after a normal night of 
drinking: a naturalistic alcohol hangover study in a non-student 
sample
Devenney LE, Coyle KB and Verster JC (2019) Addictive Behaviors 
Reports, 10 (100197).
https://www.drugsandalcohol.ie/30756/ 
The aim of this study was to investigate the effects of a normal 
night of alcohol consumption on next-day cognitive performance 
in a non-student sample.
The current study in a non-student sample confirms previous 
findings in student samples that cognitive functioning and mood 
are significantly impaired during alcohol hangover.
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Limiting psychotropic medication prescription on discharge 
from psychiatric inpatient care: a possible suicide intervention?
Cleary E, Kelleher CC, Lane A and Malone K (2019) Irish Journal of 
Psychological Medicine, Early online.
https://www.drugsandalcohol.ie/30659/ 
This study aimed to assess the quantity, toxicity and potential 
lethality of psychotropic medication being prescribed on 
discharge from psychiatric care to those with and without indices 
of suicidality.
Patient discharge from inpatient psychiatric care presents a golden 
opportunity to moderate access to potentially fatal psychotropic 
medication. Iatrogenic provision of lethal means for suicide during 
a period of increased risk and in a group at increased suicide 
risk may impact suicide prevention efforts and requires further 
in-depth research. Current prescribing practices may be a missed 
opportunity to intervene in this regard.
Sleep after heavy alcohol consumption and physical activity 
levels during alcohol hangover
Devenney LE, Coyle KB, Roth T and Verster JC (2019) Journal of 
Clinical Medicine, 8(5): 752.
https://www.drugsandalcohol.ie/30603/ 
The current study examined the impact of an evening of alcohol 
consumption on sleep, and next day activity levels and alcohol 
hangover. 
The outcome of this study underlines that, in addition to 
retrospectively reported data, real-time objective assessments are 
needed to fully understand the effects of heavy drinking.
Fetal growth and maternal alcohol consumption during early 
pregnancy
Reynolds CME, Egan B, O'Malley EG, McMahon L, Sheehan SR and 
Turner MJ (2019) European Journal of Obstetrics, Gynecology, and 
Reproductive Biology, 236: 148-153.
https://www.drugsandalcohol.ie/30588/ 
The relationship between light maternal alcohol consumption and 
fetal outcome remains contentious and the professional advice 
women receive is conflicting. The aim of this large epidemiological 
study was to examine the relationship between fetal growth and 
maternal alcohol behaviour before and during early pregnancy.
Women who consume alcohol should continue to be advised 
of the fetal and maternal risks of heavy consumption and, if 
applicable, of the need to quit smoking and avoid illicit drugs. 
However, women who have consumed alcohol before realising 
that they were pregnant, or who consumed alcohol in light 
amounts during early pregnancy, may be reassured that their 
alcohol consumption did not impact adversely on their baby's 
growth.
Dietary intakes of smokers compared to non-smokers at the 
first prenatal visit
O'Malley EG, Cawley S, Kennedy RAK, Reynolds C, Molloy and 
Turner MJ (2019) European Journal of Obstetrics, Gynecology, and 
Reproductive Biology, 234: e159.
https://www.drugsandalcohol.ie/30587/ 
In this prospective study, we compared the dietary intakes of 
micronutrients and macronutrients at the first prenatal visit of 
women who reported continuing to smoke during pregnancy with 
the intakes of women who were non-smokers.
We found that women who continue to smoke during pregnancy 
have serious dietary inadequacies which potentially may aggravate 
fetal growth restriction. This provides a further reason to promote 
smoking cessation interventions in pregnancy and highlights the 
need for dietary and supplementation interventions in women 
who continue to smoke.
The role of sex and age on pre-drinking: an exploratory 
international comparison of 27 countries
Ferris J, Puljević C, Labhart F, Winstock A and Kuntsche E (2019) 
Alcohol and Alcoholism, 54(4): 378–385.
https://www.drugsandalcohol.ie/30519/ 
This exploratory study aims to model the impact of sex and age 
on the percentage of pre-drinking in 27 countries, presenting a 
single model of pre-drinking behaviour for all countries and then 
comparing the role of sex and age on pre-drinking behaviour 
between countries.
Pre-drinking is a worldwide phenomenon, but varies substantially 
by sex and age between countries. These variations suggest that 
policy-makers would benefit from increased understanding of the 
particularities of pre-drinking in their own country to efficiently 
target harmful pre-drinking behaviours.
Global alcohol exposure between 1990 and 2017 and forecasts 
until 2030: a modelling study
Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C and Rehm J 
(2019) Lancet, 393 (10190): 2493–2502.
https://www.drugsandalcohol.ie/30508/ 
Alcohol use is a leading risk factor for global disease burden, 
and data on alcohol exposure are crucial to evaluate progress in 
achieving global non-communicable disease goals. We present 
estimates on the main indicators of alcohol exposure for 189 
countries from 1990–2017, with forecasts up to 2030.
Based on these data, global goals for reducing the harmful use 
of alcohol are unlikely to be achieved, and known effective and 
cost-effective policy measures should be implemented to reduce 
alcohol exposure.
Recent publications   continued
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Comparison of the health and wellbeing of smoking and non-
smoking school-aged children in Ireland
Evans DS, O'Farrell A, Sheridan A and Kavanagh P (2019) Child: 
Care, Health and Development, 45(5): 694–701.
https://www.drugsandalcohol.ie/30503/ 
The study aimed to determine the association between smoking 
and health and wellbeing indicators among Irish school-aged 
children.
The findings can be utilised to counteract positive perceptions 
of smoking among schoolchildren. This, combined with providing 
supports to help children quit may help achieve government 
targets to reduce smoking prevalence.
POLICY
Women as vulnerable subjects: a gendered reading of the 
English and Irish drug strategies
Wincup E (2019) Addictive Behaviors, 98: 105995.
https://www.drugsandalcohol.ie/30789/ 
Highlights
• Both strategies use vulnerability to understand women's 
pathways into/out of drugs.
• The UK strategy concentrates on ‘victimized’ women who 
are vulnerable to drug use.
• The Irish strategy focuses on women's continuing drug use 
due to poor service provision.
• Both strategies fall short of a gender-responsive approach 
to drug policy.
• Gender mainstreaming is needed to develop more inclusive 
drug policies.
Brexit threatens the UK's ability to tackle illicit drugs and 
organised crime: What needs to happen now?
Roman-Urrestarazu A, Yang J, Robertson R, McCallum A, 
Gray C, McKee M and Middleton J (2019) Health Policy, 123(6): 
521–525.
https://www.drugsandalcohol.ie/30580/  
The decision by the UK government to leave the European 
Union comes at a time when parts of the UK are experiencing 
a marked rise in reported gun and knife crimes. The health 
effects of Brexit will have serious consequences as to how the 
UK tackles this upsurge in drug-related crime.
The scale of collaboration between the UK and European 
institutions is extensive. It is not clear how this might be 
replicated after Brexit. Yet an alternative framework of 
collaboration between the UK and the EU is clearly needed to 
facilitate shared and agreed approaches to data sharing and 
drug surveillance after Brexit.
RESPONSES
Evaluating peer-supported screening as a hepatitis C case-
finding model in prisoners
Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, 
et al. (2019) Harm Reduction Journal, 16(1): 42.
https://www.drugsandalcohol.ie/30754/   
This study's primary aim is to evaluate peer-supported 
screening as a model of active HCV [hepatitis C virus] case 
finding with a secondary aim to describe the HCV cascade 
among those infected including linkage to care and treatment 
outcomes.
Peer-supported screening is an effective active HCV case-
finding model to find and link prisoners with untreated active 
HCV infection to HCV care.
Recovery in homelessness: the influence of choice and 
mastery on physical health, psychiatric symptoms, alcohol 
and drug use, and community integration
Manning RM and Greenwood RM (2019) Psychiatric 
Rehabilitation Journal, 42(2): 147–157.
https://www.drugsandalcohol.ie/30634/   
The purpose of this study was to test the hypothesis that choice 
in housing and services would predict recovery in a number of 
domains, and that these relationships would be mediated by 
mastery.
Findings add further support to the growing body of evidence 
that suggests choice is centrally important to recovery 
experiences among individuals in homelessness.
Smoking cessation interventions
Lowry-Lehnen T (2019) Update Respiratory Medicine, 5(5): 35-38.
https://www.drugsandalcohol.ie/30569/ 
The number of smokers in Ireland has decreased by an 
estimated 80,000 people over the past three years. The 
prevalence of smoking dropped from 23 per cent in 2015 to 20 
per cent in 2018. So about 20 per cent of the population are 
current smokers; 17 per cent are daily smokers, down from 19 
per cent in 2017, and 44 per cent of all smokers have made an 
attempt to quit in the past 12 months (Healthy Ireland 2018). 
While much progress has been made, tobacco use is still the 
leading cause of preventable death in Ireland with almost 6,000 
smokers dying each year from tobacco-related diseases.
Recent publications   continued
Drugnet Ireland is the quarterly 
newsletter of Ireland’s focal  
point for the EMCDDA and is 
produced in collaboration with the 
HRB National Drugs Library. Drugnet 
Ireland is published by  
the Health Research Board.
Managing editor: Brian Galvin 
Copy-editing: O’Hanlon Media
 
© Health Research Board, 2019 
 
Health Research Board 
Grattan House 
67—72 Lower Mount Street 
Dublin 2 
D02 H638
T: 01 234 5168 
E: drugnet@hrb.ie
W: www.hrb.ie
